STUDYID,USUBJID,SUBJID,SITEID,AGE,AGEU,AGEGR1,AGEGR1N,AGEGR2,AGEGR2N,SEX,RACE,RACEN,COUNTRY,COUNTRYC,REGION,REGIONN,REGNGR1,REGNGR1N,REGNGR2,REGNGR2N,STRATA1,STRATA2,ECOG,ECOGGR1,ECOGGR1N,HEIGHT,HGTGR1,HGTGR1N,WEIGHT,WGTGR1,WGTGR1N,BSA,BSAGR1,BSAGR1N,BCA199,BCAGR1,BCAGR1N,SAFFL,ITTFL,HITTFL,TEVLFL,CAEVLFL,ARM,TRT01P,TRT01PN,TRT01A,TRT01AN,HENT1ST,HENT1STN,DSREAS,DSREASN,DSTERM,DTHFL,DEATHDSC,DTHDTC,DEATHDY,LASTVDT,LASTCDT,CUTOFFDT,STATUS,STATUSN,RANDDUR,DIAGDUR,DIAGGR1,DIAGGR1N,METDDUR,METDGR1,METDGR1N,DGMTDUR,MEASDFL,METDFL,MLOCN,MLOCGR1,MLOCGR1N,METLIV,METLYM,METPERI,METLUNG,METBRAIN,METKIDNY,METOTH,HCGRAD,PTLOC,PTCLAS,RGCLAS,RES10X,R10XGR1,R10XGR1N
CO-101-001,CO-101-001-001-001,01001001,001,70.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,175.5,>175,6.0,66.0,>50-75,2.0,1.81,>1.75-2.0,4.0,9420.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-21,446.0,2012-01-02,2012-01-02,2012-10-01,Died,2.0,2.0,1.5441478439425051,<=3,1.0,1.5441478439425051,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,TAIL OF PANCREAS,T3,N0,15,11-20,2.0
CO-101-001,CO-101-001-001-005,01001005,001,46.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,170.0,>150-175,5.0,52.5,>50-75,2.0,1.59,>1.50-1.75,3.0,422.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-01-12,255.0,2012-01-06,2012-01-06,2012-10-01,Died,2.0,1.0,2.8254620123203287,<=3,1.0,1.8069815195071868,<=3,1.0,1.051334702258727,Y,Y,2.0,2,2.0,Y,,Y,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N0,5,0-10,1.0
CO-101-001,CO-101-001-001-006,01001006,001,69.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,169.0,>150-175,5.0,69.2,>50-75,2.0,1.79,>1.75-2.0,4.0,508.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-08-31,2012-08-31,2012-10-01,Alive,1.0,1.0,24.147843942505133,>24,5.0,1.4455852156057496,<=3,1.0,22.73511293634497,Y,Y,3.0,3,3.0,,Y,Y,,,,Y,G1 - Well differentiated,HEAD OF PANCREAS,T3,N0,10,0-10,1.0
CO-101-001,CO-101-001-001-008,01001008,001,70.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,172.0,>150-175,5.0,59.2,>50-75,2.0,1.7,>1.50-1.75,3.0,732.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-07,7.0,2011-11-01,,2012-10-01,Died,2.0,1.0,16.525667351129364,>12-24,4.0,1.6098562628336757,<=3,1.0,14.948665297741274,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T2,N0,10,0-10,1.0
CO-101-001,CO-101-001-001-010,01001010,001,65.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,NOR,NORWAY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,,,,,,,,,,,,,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-06-08,,2012-05-24,2012-05-24,2012-10-01,Died,2.0,,2.102669404517454,<=3,1.0,0.8870636550308009,<=3,1.0,1.2484599589322383,N,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T4,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-003-001,01003001,003,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,172.0,>150-175,5.0,74.0,>50-75,2.0,1.87,>1.75-2.0,4.0,12800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-13,267.0,2011-09-29,2011-09-29,2012-10-01,Died,2.0,1.0,1.7084188911704312,<=3,1.0,1.6427104722792607,<=3,1.0,0.09856262833675565,Y,Y,2.0,2,2.0,Y,Y,,,,,,G1 - Well differentiated,BODY OF PANCREAS,T2,N1,20,11-20,2.0
CO-101-001,CO-101-001-003-002,01003002,003,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,169.0,>150-175,5.0,56.0,>50-75,2.0,1.62,>1.50-1.75,3.0,41900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-20,392.0,2012-05-16,2012-06-20,2012-10-01,Died,2.0,1.0,1.2813141683778233,<=3,1.0,1.2813141683778233,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-003-003,01003003,003,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,155.0,>150-175,5.0,48.0,<=50,1.0,1.43,>1.25-1.50,2.0,2630.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-02-25,257.0,2012-01-16,2012-01-16,2012-10-01,Died,2.0,9.0,48.558521560574945,>24,5.0,41.59342915811088,>24,5.0,6.997946611909651,Y,Y,5.0,>=5,5.0,Y,Y,,Y,,,Y,G1 - Well differentiated,HEAD OF PANCREAS,T3,Nx,30,21-30,3.0
CO-101-001,CO-101-001-003-005,01003005,003,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,160.0,>150-175,5.0,52.6,>50-75,2.0,1.53,>1.50-1.75,3.0,283.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-07,218.0,2012-08-02,2012-08-20,2012-10-01,Died,2.0,1.0,1.6427104722792607,<=3,1.0,0.8870636550308009,<=3,1.0,0.7885010266940452,Y,Y,2.0,2,2.0,,Y,Y,,,,,Unknown,HEAD OF PANCREAS,T3,N1,5,0-10,1.0
CO-101-001,CO-101-001-005-001,01005001,005,62.0,YEARS,61-70,3.0,<65,1.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,160.0,>150-175,5.0,53.0,>50-75,2.0,1.54,>1.50-1.75,3.0,17600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-21,142.0,2011-07-13,2011-07-21,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.3942505133470226,<=3,1.0,0.6242299794661191,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,Unknown,TAIL OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-005-003,01005003,005,69.0,YEARS,61-70,3.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,160.0,>150-175,5.0,43.0,<=50,1.0,1.41,>1.25-1.50,2.0,8320.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-03,310.0,2012-01-03,2012-01-03,2012-10-01,Died,2.0,2.0,2.726899383983573,<=3,1.0,0.4271047227926078,<=3,1.0,2.3326488706365502,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,TAIL OF PANCREAS,T4,N1,2,0-10,1.0
CO-101-001,CO-101-001-007-002,01007002,007,66.0,YEARS,61-70,3.0,>=65,2.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,165.0,>150-175,5.0,80.0,>75-100,3.0,1.87,>1.75-2.0,4.0,1030000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,HEPATIC ENCEPHALOPATHY,2011-05-01,52.0,2011-04-19,,2012-10-01,Died,2.0,1.0,1.51129363449692,<=3,1.0,0.9856262833675564,<=3,1.0,0.5585215605749486,Y,Y,1.0,1,1.0,Y,,,,,,,G1 - Well differentiated,TAIL OF PANCREAS,Tx,Nx,2,0-10,1.0
CO-101-001,CO-101-001-007-003,01007003,007,63.0,YEARS,61-70,3.0,<65,1.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,178.0,>175,6.0,85.0,>75-100,3.0,2.0,>1.75-2.0,4.0,118.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-26,49.0,2011-07-15,,2012-10-01,Died,2.0,3.0,1.839835728952772,<=3,1.0,1.839835728952772,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-007-004,01007004,007,46.0,YEARS,<=50,1.0,<65,1.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,185.0,>175,6.0,74.0,>50-75,2.0,1.95,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-14,237.0,2012-02-01,2012-02-01,2012-10-01,Died,2.0,4.0,1.0841889117043122,<=3,1.0,0.919917864476386,<=3,1.0,0.1971252566735113,Y,Y,1.0,1,1.0,Y,,,,,,,G1 - Well differentiated,TAIL OF PANCREAS,Tx,Nx,2,0-10,1.0
CO-101-001,CO-101-001-007-005,01007005,007,64.0,YEARS,61-70,3.0,<65,1.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,196.0,>175,6.0,78.0,>75-100,3.0,2.0,>1.75-2.0,4.0,6690.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,2.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,Tx,Nx,0,0-10,1.0
CO-101-001,CO-101-001-007-006,01007006,007,61.0,YEARS,61-70,3.0,<65,1.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,182.0,>175,6.0,76.0,>75-100,3.0,1.96,>1.75-2.0,4.0,40000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-31,129.0,2012-05-09,,2012-10-01,Died,2.0,1.0,2.004106776180698,<=3,1.0,2.004106776180698,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,Nx,15,11-20,2.0
CO-101-001,CO-101-001-007-007,01007007,007,67.0,YEARS,61-70,3.0,>=65,2.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,178.0,>175,6.0,60.0,>50-75,2.0,1.7,>1.50-1.75,3.0,39600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-23,115.0,2012-05-31,,2012-10-01,Died,2.0,3.0,1.0841889117043122,<=3,1.0,1.0841889117043122,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-009-001,01009001,009,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.9,>150-175,5.0,62.1,>50-75,2.0,1.68,>1.50-1.75,3.0,12.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-03-28,420.0,2012-03-26,2012-03-28,2012-10-01,Died,2.0,2.0,3.9425051334702257,>3-6,2.0,1.4455852156057496,<=3,1.0,2.529774127310062,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T3,N1,50,41-50,5.0
CO-101-001,CO-101-001-009-002,01009002,009,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,,,,,,,,,,,,,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,,,,,2012-10-16,2012-10-16,2012-10-01,Alive,1.0,,1.3141683778234086,<=3,1.0,1.0841889117043122,<=3,1.0,0.26283367556468173,N,Y,1.0,1,1.0,,,,Y,,,,Unknown,BODY OF PANCREAS,T4,N0,40,31-40,4.0
CO-101-001,CO-101-001-015-001,01015001,015,76.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,162.0,>150-175,5.0,70.8,>50-75,2.0,1.76,>1.75-2.0,4.0,8.1,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,,,,,,,,2012-11-05,,2012-10-01,,,1.0,2.2669404517453797,<=3,1.0,0.8542094455852156,<=3,1.0,1.4455852156057496,Y,Y,2.0,2,2.0,,Y,Y,,,,,Unknown,BODY OF PANCREAS,T2,N1,2,0-10,1.0
CO-101-001,CO-101-001-015-002,01015002,015,70.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,172.0,>150-175,5.0,60.0,>50-75,2.0,1.71,>1.50-1.75,3.0,406.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-10,271.0,2011-08-21,2011-08-21,2012-10-01,Died,2.0,2.0,0.6242299794661191,<=3,1.0,0.6242299794661191,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T2,N1,0,0-10,1.0
CO-101-001,CO-101-001-015-003,01015003,015,67.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,164.0,>150-175,5.0,45.3,<=50,1.0,1.47,>1.25-1.50,2.0,622.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2011-08-14,200.0,2011-07-12,2011-12-15,2012-10-01,Died,2.0,2.0,1.3470225872689938,<=3,1.0,1.3470225872689938,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T4,N1,60,51-60,6.0
CO-101-001,CO-101-001-015-004,01015004,015,86.0,YEARS,81-90,5.0,>=65,2.0,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,166.0,>150-175,5.0,61.7,>50-75,2.0,1.69,>1.50-1.75,3.0,6950.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-03,59.0,2011-10-18,,2012-10-01,Died,2.0,2.0,2.5626283367556466,<=3,1.0,0.8542094455852156,<=3,1.0,1.7412731006160165,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T2,N1,20,11-20,2.0
CO-101-001,CO-101-001-015-005,01015005,015,72.0,YEARS,71-80,4.0,>=65,2.0,M,BLACK OR AFRICAN AMERICAN,3.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,161.0,>150-175,5.0,71.4,>50-75,2.0,1.75,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-01,2012-10-01,2012-10-01,Alive,1.0,1.0,2.3655030800821355,<=3,1.0,2.102669404517454,<=3,1.0,0.29568788501026694,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-015-006,01015006,015,59.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,BEL,BELGIUM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,183.0,>175,6.0,79.0,>75-100,3.0,2.0,>1.75-2.0,4.0,11000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,2.0,1.3141683778234086,<=3,1.0,0.7227926078028748,<=3,1.0,0.6242299794661191,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T1,N0,15,11-20,2.0
CO-101-001,CO-101-001-017-001,01017001,017,79.0,YEARS,71-80,4.0,>=65,2.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.0,>150-175,5.0,60.0,>50-75,2.0,1.62,>1.50-1.75,3.0,167.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2010-09-01,28.0,2010-08-13,,2012-10-01,Died,2.0,2.0,10.611909650924025,>6-12,3.0,1.4784394250513346,<=3,1.0,9.166324435318275,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,Unknown,BODY OF PANCREAS,Unknown,N0,40,31-40,4.0
CO-101-001,CO-101-001-017-002,01017002,017,74.0,YEARS,71-80,4.0,>=65,2.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,176.0,>175,6.0,73.0,>50-75,2.0,1.89,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-15,2012-10-15,2012-10-01,Alive,1.0,29.0,1.839835728952772,<=3,1.0,1.4455852156057496,<=3,1.0,0.4271047227926078,Y,Y,2.0,2,2.0,Y,Y,,,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,Tx,N0,0,0-10,1.0
CO-101-001,CO-101-001-018-001,01018001,018,51.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,168.0,>150-175,5.0,73.0,>50-75,2.0,1.85,>1.75-2.0,4.0,62300.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,DEATH,2.0,TUMOR BLEEDING DUE TO TUMOR INVASION IN DUODENUM,Y,TUMOR BLEEDING DUE TO TUMOR INVASION IN DUODENUM,2011-03-27,55.0,2011-03-22,,2012-10-01,Died,2.0,1.0,2.924024640657084,<=3,1.0,1.215605749486653,<=3,1.0,1.7412731006160165,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,HEAD OF PANCREAS,Unknown,Unknown,90,81-90,9.0
CO-101-001,CO-101-001-019-001,01019001,019,65.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,172.0,>150-175,5.0,82.0,>75-100,3.0,1.95,>1.75-2.0,4.0,3320.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-08-30,2012-08-30,2012-10-01,Alive,1.0,1.0,1.9055441478439425,<=3,1.0,1.9055441478439425,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-019-002,01019002,019,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,,,,,,,,,,,,,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,CAUSE UNKNOWN,2011-07-20,,2011-07-04,2011-07-20,2012-10-01,Died,2.0,,0.5585215605749486,<=3,1.0,0.5585215605749486,<=3,1.0,0.03285420944558522,N,Y,1.0,1,1.0,Y,,,,,,,Unknown,TAIL OF PANCREAS,Tx,Nx,40,31-40,4.0
CO-101-001,CO-101-001-019-004,01019004,019,66.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,163.0,>150-175,5.0,79.0,>75-100,3.0,1.85,>1.75-2.0,4.0,6720.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-02-09,177.0,2012-01-09,2012-02-14,2012-10-01,Died,2.0,2.0,1.0841889117043122,<=3,1.0,0.75564681724846,<=3,1.0,0.3613963039014374,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N1,50,41-50,5.0
CO-101-001,CO-101-001-019-005,01019005,019,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,164.0,>150-175,5.0,48.0,<=50,1.0,1.5,>1.25-1.50,2.0,285.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,OTHER,8.0,DUE TO WRONG RADIOLOGICAL DIAGNOSIS OF PD THE PATIENT WAS TAKEN OFF TRIAL.,Y,DISEASE PROGRESSION,2011-12-25,131.0,2011-12-12,2011-12-28,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.6899383983572895,<=3,1.0,0.32854209445585214,Y,Y,2.0,2,2.0,Y,,,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N0,60,51-60,6.0
CO-101-001,CO-101-001-020-001,01020001,020,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,169.0,>150-175,5.0,79.8,>75-100,3.0,1.91,>1.75-2.0,4.0,2280.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-08,363.0,2012-01-05,2012-01-05,2012-10-01,Died,2.0,2.0,0.9527720739219713,<=3,1.0,0.5256673511293635,<=3,1.0,0.459958932238193,Y,Y,1.0,1,1.0,,,,Y,,,,Unknown,TAIL OF PANCREAS,Unknown,Unknown,10,0-10,1.0
CO-101-001,CO-101-001-020-003,01020003,020,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,185.0,>175,6.0,77.0,>75-100,3.0,1.99,>1.75-2.0,4.0,1130.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-01,160.0,2011-12-14,2011-12-14,2012-10-01,Died,2.0,2.0,1.3470225872689938,<=3,1.0,0.8870636550308009,<=3,1.0,0.4928131416837782,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Tx,Nx,20,11-20,2.0
CO-101-001,CO-101-001-020-005,01020005,020,54.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,190.0,>175,6.0,105.3,>100-125,4.0,2.36,>2.0,5.0,138000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-05,254.0,2012-06-12,2012-07-31,2012-10-01,Died,2.0,1.0,1.215605749486653,<=3,1.0,0.6570841889117043,<=3,1.0,0.5913757700205339,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Tx,N1,50,41-50,5.0
CO-101-001,CO-101-001-020-006,01020006,020,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,170.0,>150-175,5.0,73.2,>50-75,2.0,1.86,>1.75-2.0,4.0,211.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-07,260.0,2012-09-19,2012-08-09,2012-10-01,Died,2.0,2.0,0.4271047227926078,<=3,1.0,0.6570841889117043,<=3,1.0,-0.1971252566735113,Y,Y,2.0,2,2.0,,Y,,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N1,55,51-60,6.0
CO-101-001,CO-101-001-021-001,01021001,021,72.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,184.0,>175,6.0,68.0,>50-75,2.0,1.92,>1.75-2.0,4.0,38.8,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,CAUSE UNKNOWN,2011-10-30,308.0,2012-02-08,2012-06-06,2012-10-01,Died,2.0,5.0,0.5585215605749486,<=3,1.0,0.5585215605749486,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,Y,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,Nx,40,31-40,4.0
CO-101-001,CO-101-001-021-004,01021004,021,77.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,178.0,>175,6.0,64.0,>50-75,2.0,1.8,>1.75-2.0,4.0,99000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-09,167.0,2011-08-01,,2012-10-01,Died,2.0,1.0,0.5913757700205339,<=3,1.0,0.5913757700205339,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,OTHER,T2,N1,0,0-10,1.0
CO-101-001,CO-101-001-021-005,01021005,021,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,174.0,>150-175,5.0,103.0,>100-125,4.0,2.2,>2.0,5.0,8810.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-27,154.0,2011-07-21,,2012-10-01,Died,2.0,1.0,0.5256673511293635,<=3,1.0,0.5256673511293635,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,TAIL OF PANCREAS,T3,N0,0,0-10,1.0
CO-101-001,CO-101-001-021-006,01021006,021,77.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,178.0,>175,6.0,85.0,>75-100,3.0,2.04,>2.0,5.0,6.5,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,,,,,,,,2012-11-05,,2012-10-01,,,2.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,Y,Y,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T4,Nx,55,51-60,6.0
CO-101-001,CO-101-001-021-007,01021007,021,62.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,175.0,>150-175,5.0,74.0,>50-75,2.0,1.91,>1.75-2.0,4.0,130.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-11-06,2012-11-06,2012-10-01,Alive,1.0,2.0,0.5913757700205339,<=3,1.0,0.5913757700205339,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,,,,,,Y,Unknown,BODY OF PANCREAS,T1,Nx,60,51-60,6.0
CO-101-001,CO-101-001-022-003,01022003,022,45.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,176.0,>175,6.0,71.1,>50-75,2.0,1.85,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-09,159.0,2012-06-05,2012-06-05,2012-10-01,Died,2.0,2.0,1.0841889117043122,<=3,1.0,0.6242299794661191,<=3,1.0,0.4928131416837782,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,5,0-10,1.0
CO-101-001,CO-101-001-023-001,01023001,023,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,168.0,>150-175,5.0,43.6,<=50,1.0,1.44,>1.25-1.50,2.0,43900.0,>50xULN,7.0,Y,Y,Y,N,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-04-15,93.0,2011-04-15,,2012-10-01,Died,2.0,2.0,2.595482546201232,<=3,1.0,0.9527720739219713,<=3,1.0,1.675564681724846,N,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-023-002,01023002,023,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,,,,,,,,,,,,,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-04-11,,2011-04-01,,2012-10-01,Died,2.0,,18.8911704312115,>12-24,4.0,3.7453798767967146,>3-6,2.0,15.178644763860369,N,Y,5.0,>=5,5.0,Y,Y,Y,Y,,,Y,G1 - Well differentiated,HEAD OF PANCREAS,T2,N1,50,41-50,5.0
CO-101-001,CO-101-001-024-004,01024004,024,64.0,YEARS,61-70,3.0,<65,1.0,F,OTHER,99.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,2.0,>=2,3.0,169.0,>150-175,5.0,53.4,>50-75,2.0,1.57,>1.50-1.75,3.0,172000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-12-13,12.0,2011-12-09,,2012-10-01,Died,2.0,2.0,0.7885010266940452,<=3,1.0,0.6899383983572895,<=3,1.0,0.13141683778234087,Y,Y,2.0,2,2.0,Y,,,Y,,,,G1 - Well differentiated,HEAD OF PANCREAS,Tx,Nx,50,41-50,5.0
CO-101-001,CO-101-001-025-001,01025001,025,77.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,158.0,>150-175,5.0,73.2,>50-75,2.0,1.76,>1.75-2.0,4.0,94200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-27,191.0,2011-06-14,2011-06-14,2012-10-01,Died,2.0,2.0,1.6427104722792607,<=3,1.0,1.6427104722792607,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G4 - Undifferentiated,HEAD OF PANCREAS,T2,N1,0,0-10,1.0
CO-101-001,CO-101-001-025-002,01025002,025,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,164.0,>150-175,5.0,71.4,>50-75,2.0,1.77,>1.75-2.0,4.0,171000.0,>50xULN,7.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-03-27,27.0,2011-03-08,,2012-10-01,Died,2.0,2.0,1.1498973305954825,<=3,1.0,1.1498973305954825,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T2,Unknown,N/A,,
CO-101-001,CO-101-001-025-003,01025003,025,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,,,,,,,,,,,,,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-04-14,,2011-04-07,,2012-10-01,Died,2.0,,1.0841889117043122,<=3,1.0,1.0841889117043122,<=3,1.0,0.03285420944558522,N,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,HEAD OF PANCREAS,Unknown,Unknown,20,11-20,2.0
CO-101-001,CO-101-001-029-002,01029002,029,71.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,171.5,>150-175,5.0,71.0,>50-75,2.0,1.83,>1.75-2.0,4.0,70800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,STROKE,2011-03-22,98.0,2011-03-03,2011-03-22,2012-10-01,Died,2.0,2.0,2.135523613963039,<=3,1.0,0.459958932238193,<=3,1.0,1.7084188911704312,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T2,Nx,80,71-80,8.0
CO-101-001,CO-101-001-029-003,01029003,029,69.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,180.5,>175,6.0,80.1,>75-100,3.0,2.0,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,,,,,2012-10-24,,2012-10-01,,,2.0,1.3470225872689938,<=3,1.0,0.6570841889117043,<=3,1.0,0.7227926078028748,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,T3,N1,70,61-70,7.0
CO-101-001,CO-101-001-030-004,01030004,030,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,,,,,,,,,,1.7,<=ULN,1.0,N,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,,,Positive (High),2.0,OTHER,8.0,ECOG 3,Y,DISEASE PROGRESSION,2012-03-07,,2012-02-09,2012-02-09,2012-10-01,Died,2.0,,1.51129363449692,<=3,1.0,1.51129363449692,<=3,1.0,0.03285420944558522,N,Y,5.0,>=5,5.0,Y,,Y,Y,,,Y,Unknown,TAIL OF PANCREAS,T4,Unknown,90,81-90,9.0
CO-101-001,CO-101-001-031-001,01031001,031,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,169.0,>150-175,5.0,75.0,>50-75,2.0,1.85,>1.75-2.0,4.0,385.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-30,413.0,2012-05-10,2012-06-07,2012-10-01,Died,2.0,2.0,1.3470225872689938,<=3,1.0,1.3470225872689938,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,,Y,Y,Y,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-031-002,01031002,031,75.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,173.0,>150-175,5.0,80.0,>75-100,3.0,1.94,>1.75-2.0,4.0,1930.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-15,51.0,2012-03-08,,2012-10-01,Died,2.0,3.0,1.5770020533880904,<=3,1.0,1.5770020533880904,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,,,Y,,,Y,G4 - Undifferentiated,OTHER,Unknown,Unknown,25,21-30,3.0
CO-101-001,CO-101-001-033-001,01033001,033,48.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,162.0,>150-175,5.0,87.0,>75-100,3.0,1.98,>1.75-2.0,4.0,83.2,>2xULN-3xULN,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,,,,,2012-10-10,2012-10-10,2012-10-01,Alive,1.0,2.0,1.0841889117043122,<=3,1.0,1.0841889117043122,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,,,,,,,Y,Unknown,OTHER,Tx,Nx,55,51-60,6.0
CO-101-001,CO-101-001-034-001,01034001,034,43.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,164.0,>150-175,5.0,70.5,>50-75,2.0,1.77,>1.75-2.0,4.0,298000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-22,290.0,2012-02-08,2012-02-08,2012-10-01,Died,2.0,1.0,2.004106776180698,<=3,1.0,2.004106776180698,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,TAIL OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-034-002,01034002,034,55.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,158.0,>150-175,5.0,70.5,>50-75,2.0,1.72,>1.50-1.75,3.0,9420.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-06,142.0,2012-01-05,2012-01-05,2012-10-01,Died,2.0,1.0,1.051334702258727,<=3,1.0,1.051334702258727,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,,,Y,,Y,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N0,0,0-10,1.0
CO-101-001,CO-101-001-034-003,01034003,034,58.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,155.0,>150-175,5.0,57.0,>50-75,2.0,1.55,>1.50-1.75,3.0,669.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,INTRACRANIAL HEMORRAGE,2012-05-23,266.0,2012-05-09,,2012-10-01,Died,2.0,2.0,1.0184804928131417,<=3,1.0,1.0184804928131417,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G1 - Well differentiated,HEAD OF PANCREAS,T4,N1,60,51-60,6.0
CO-101-001,CO-101-001-034-004,01034004,034,38.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,157.0,>150-175,5.0,57.0,>50-75,2.0,1.57,>1.50-1.75,3.0,250000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-26,104.0,2012-04-26,,2012-10-01,Died,2.0,4.0,1.0184804928131417,<=3,1.0,1.0184804928131417,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-036-001,01036001,036,71.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,156.0,>150-175,5.0,38.8,<=50,1.0,1.3,>1.25-1.50,2.0,311000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,RESPIRATORY INSUFFICIENCE,Y,RESPIRATORY INSUFFICIENCE,2011-07-04,35.0,2011-06-28,,2012-10-01,Died,2.0,2.0,0.6242299794661191,<=3,1.0,0.6242299794661191,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,OTHER,T3,Nx,15,11-20,2.0
CO-101-001,CO-101-001-036-002,01036002,036,40.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,159.0,>150-175,5.0,52.1,>50-75,2.0,1.52,>1.50-1.75,3.0,98900.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-04,23.0,2011-07-27,,2012-10-01,Died,2.0,2.0,0.6570841889117043,<=3,1.0,0.6570841889117043,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,G2 - Moderately differentiated,OTHER,T3,Nx,70,61-70,7.0
CO-101-001,CO-101-001-036-003,01036003,036,77.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,157.0,>150-175,5.0,58.7,>50-75,2.0,1.6,>1.50-1.75,3.0,111.0,>2xULN-3xULN,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,,,,,2011-11-10,,2012-10-01,Lost to Follow-up,3.0,3.0,1.3470225872689938,<=3,1.0,1.1170431211498972,<=3,1.0,0.26283367556468173,Y,Y,1.0,1,1.0,,,,Y,,,,Unknown,HEAD OF PANCREAS,T4,Nx,50,41-50,5.0
CO-101-001,CO-101-001-037-001,01037001,037,71.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,155.0,>150-175,5.0,46.0,<=50,1.0,1.37,>1.25-1.50,2.0,59000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-14,166.0,2012-01-20,2012-01-20,2012-10-01,Died,2.0,3.0,1.0184804928131417,<=3,1.0,1.0184804928131417,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,HEAD OF PANCREAS,Tx,Nx,40,31-40,4.0
CO-101-001,CO-101-001-037-002,01037002,037,70.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,165.0,>150-175,5.0,81.2,>75-100,3.0,1.85,>1.75-2.0,4.0,33400.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-14,13.0,2011-09-09,,2012-10-01,Died,2.0,3.0,1.379876796714579,<=3,1.0,1.379876796714579,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,,Y,,,,Y,Unknown,BODY OF PANCREAS,T2,N0,30,21-30,3.0
CO-101-001,CO-101-001-037-003,01037003,037,60.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,169.0,>150-175,5.0,86.0,>75-100,3.0,1.9,>1.75-2.0,4.0,8520.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-09-16,367.0,2012-08-16,2012-09-18,2012-10-01,Died,2.0,1.0,0.5913757700205339,<=3,1.0,0.5913757700205339,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,,Y,,,Y,Unknown,TAIL OF PANCREAS,Tx,Nx,0,0-10,1.0
CO-101-001,CO-101-001-039-001,01039001,039,58.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,177.5,>175,6.0,73.8,>50-75,2.0,1.91,>1.75-2.0,4.0,1600.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-10,536.0,2012-04-04,2012-06-15,2012-10-01,Died,2.0,2.0,1.215605749486653,<=3,1.0,1.215605749486653,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N0,70,61-70,7.0
CO-101-001,CO-101-001-039-002,01039002,039,51.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,189.0,>175,6.0,86.9,>75-100,3.0,2.14,>2.0,5.0,965000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-03,97.0,2011-09-21,2011-09-21,2012-10-01,Died,2.0,2.0,1.5441478439425051,<=3,1.0,1.5441478439425051,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,T3,N1,30,21-30,3.0
CO-101-001,CO-101-001-039-004,01039004,039,55.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.0,>150-175,5.0,56.0,>50-75,2.0,1.62,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-31,48.0,2011-09-14,2011-10-31,2012-10-01,Died,2.0,1.0,1.5770020533880904,<=3,1.0,1.5770020533880904,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,Y,,,,Y,G2 - Moderately differentiated,TAIL OF PANCREAS,Tx,Nx,90,81-90,9.0
CO-101-001,CO-101-001-039-005,01039005,039,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,168.0,>150-175,5.0,90.8,>75-100,3.0,2.01,>2.0,5.0,15800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-17,104.0,2012-03-19,2012-03-19,2012-10-01,Died,2.0,2.0,1.8726899383983573,<=3,1.0,1.8726899383983573,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Tx,Nx,70,61-70,7.0
CO-101-001,CO-101-001-041-001,01041001,041,74.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,163.2,>150-175,5.0,55.0,>50-75,2.0,1.6,>1.50-1.75,3.0,4310.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROTOCOL VIOLATION,4.0,PROTOCOL VIOLATION,Y,DISEASE PROGRESSION,2011-08-02,120.0,2011-07-07,2011-07-07,2012-10-01,Died,2.0,2.0,1.2813141683778233,<=3,1.0,1.2813141683778233,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,,Y,Y,,,,Unknown,BODY OF PANCREAS,Unknown,Unknown,50,41-50,5.0
CO-101-001,CO-101-001-041-003,01041003,041,49.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,163.0,>150-175,5.0,71.8,>50-75,2.0,1.79,>1.75-2.0,4.0,492000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-06,113.0,2011-08-23,2011-08-23,2012-10-01,Died,2.0,2.0,1.4127310061601643,<=3,1.0,1.4127310061601643,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,Unknown,BODY OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-041-004,01041004,041,67.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,173.0,>150-175,5.0,80.8,>75-100,3.0,1.95,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2011-12-31,229.0,2011-12-20,2011-12-20,2012-10-01,Died,2.0,2.0,1.2813141683778233,<=3,1.0,1.2813141683778233,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,Unknown,Unknown,20,11-20,2.0
CO-101-001,CO-101-001-041-006,01041006,041,77.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,164.0,>150-175,5.0,78.3,>75-100,3.0,1.86,>1.75-2.0,4.0,95200.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-17,31.0,2011-11-01,,2012-10-01,Died,2.0,1.0,2.924024640657084,<=3,1.0,1.6427104722792607,<=3,1.0,1.3141683778234086,Y,Y,2.0,2,2.0,,Y,Y,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,Tx,Nx,60,51-60,6.0
CO-101-001,CO-101-001-041-007,01041007,041,69.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,186.0,>175,6.0,85.8,>75-100,3.0,2.12,>2.0,5.0,12300.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,,,,,2012-10-25,2012-10-25,2012-10-01,Alive,1.0,2.0,1.379876796714579,<=3,1.0,1.1170431211498972,<=3,1.0,0.29568788501026694,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,,Unknown,15,11-20,2.0
CO-101-001,CO-101-001-041-008,01041008,041,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,175.0,>150-175,5.0,72.8,>50-75,2.0,1.9,>1.75-2.0,4.0,793.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-04,79.0,2012-03-20,,2012-10-01,Died,2.0,2.0,2.431211498973306,<=3,1.0,2.431211498973306,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,Y,Y,,,,Y,Unknown,BODY OF PANCREAS,Unknown,Unknown,90,81-90,9.0
CO-101-001,CO-101-001-041-009,01041009,041,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,156.0,>150-175,5.0,61.8,>50-75,2.0,1.59,>1.50-1.75,3.0,171000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-27,95.0,2012-03-22,,2012-10-01,Died,2.0,2.0,1.3470225872689938,<=3,1.0,1.3470225872689938,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,,,,,,Y,Unknown,TAIL OF PANCREAS,Unknown,Unknown,10,0-10,1.0
CO-101-001,CO-101-001-042-001,01042001,042,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,ARG,ARGENTINA,South America,5.0,Australia/South America,4.0,South America,3.0,0.0,3.0,0.0,0,1.0,168.0,>150-175,5.0,68.5,>50-75,2.0,1.78,>1.75-2.0,4.0,,,,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-19,199.0,2011-10-28,,2012-10-01,Died,2.0,2.0,0.8870636550308009,<=3,1.0,0.8870636550308009,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,T1,Nx,N/A,,
CO-101-001,CO-101-001-044-001,01044001,044,49.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,167.6,>150-175,5.0,107.0,>100-125,4.0,2.2,>2.0,5.0,1520.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-05,451.0,2012-01-27,2012-01-27,2012-10-01,Died,2.0,1.0,0.3942505133470226,<=3,1.0,0.3942505133470226,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,T4,Nx,30,21-30,3.0
CO-101-001,CO-101-001-044-002,01044002,044,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,170.5,>150-175,5.0,55.9,>50-75,2.0,1.62,>1.50-1.75,3.0,24700.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-22,112.0,2011-05-05,,2012-10-01,Died,2.0,1.0,1.7412731006160165,<=3,1.0,1.7412731006160165,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-044-003,01044003,044,50.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,AUS,AUSTRALIA,Australia,4.0,Australia/South America,4.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,168.5,>150-175,5.0,137.1,>125-150,5.0,2.5,>2.0,5.0,9160.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,SYMPTOMATIC/CLINICALLY PROGRESSED,2011-12-07,247.0,2011-11-21,2011-11-21,2012-10-01,Died,2.0,2.0,0.8213552361396304,<=3,1.0,0.8213552361396304,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,Nx,80,71-80,8.0
CO-101-001,CO-101-001-045-001,01045001,045,46.0,YEARS,<=50,1.0,<65,1.0,F,OTHER,99.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,162.0,>150-175,5.0,55.5,>50-75,2.0,1.55,>1.50-1.75,3.0,44.8,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-07,200.0,2012-03-16,2012-04-09,2012-10-01,Died,2.0,2.0,1.675564681724846,<=3,1.0,1.5441478439425051,<=3,1.0,0.16427104722792607,Y,Y,2.0,2,2.0,Y,,,,,,Y,Unknown,HEAD OF PANCREAS,Tx,Nx,95,91-100,10.0
CO-101-001,CO-101-001-046-001,01046001,046,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,156.0,>150-175,5.0,53.0,>50-75,2.0,1.51,>1.50-1.75,3.0,125000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,OTHER,8.0,INVESTIGATOR DECISION,Y,DISEASE PROGRESSION,2011-09-10,73.0,2011-08-24,2011-09-22,2012-10-01,Died,2.0,2.0,2.858316221765914,<=3,1.0,2.858316221765914,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Tx,Nx,60,51-60,6.0
CO-101-001,CO-101-001-046-002,01046002,046,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,160.0,>150-175,5.0,56.0,>50-75,2.0,1.57,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,CLINICAL DETERIORATION,2012-02-02,106.0,2012-01-16,,2012-10-01,Died,2.0,1.0,1.6098562628336757,<=3,1.0,1.6098562628336757,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,HEAD OF PANCREAS,T4,N0,50,41-50,5.0
CO-101-001,CO-101-001-047-001,01047001,047,65.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,BRA,BRAZIL,South America,5.0,Australia/South America,4.0,South America,3.0,1.0,3.0,1.0,1,2.0,155.0,>150-175,5.0,50.0,<=50,1.0,1.47,>1.25-1.50,2.0,17800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,INFECTION WITH UNKNOWN NEUTROPHIL COUNT,2011-10-26,79.0,2011-10-11,2011-11-10,2012-10-01,Died,2.0,2.0,6.209445585215605,>6-12,3.0,1.3141683778234086,<=3,1.0,4.9281314168377826,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Unknown,Unknown,80,71-80,8.0
CO-101-001,CO-101-001-050-002,01050002,050,37.0,YEARS,<=50,1.0,<65,1.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,180.0,>175,6.0,65.2,>50-75,2.0,1.83,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,PANCREATIC ADENOCARCINOMA CANCER PROGRESSION,2011-04-08,78.0,2011-04-01,,2012-10-01,Died,2.0,1.0,0.8213552361396304,<=3,1.0,0.75564681724846,<=3,1.0,0.09856262833675565,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,T4,N1,90,81-90,9.0
CO-101-001,CO-101-001-050-003,01050003,050,39.0,YEARS,<=50,1.0,<65,1.0,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,164.0,>150-175,5.0,50.0,<=50,1.0,1.53,>1.50-1.75,3.0,1380.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-28,370.0,2012-01-11,2012-01-11,2012-10-01,Died,2.0,1.0,0.5913757700205339,<=3,1.0,0.5913757700205339,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,N0,70,61-70,7.0
CO-101-001,CO-101-001-050-005,01050005,050,68.0,YEARS,61-70,3.0,>=65,2.0,F,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,161.0,>150-175,5.0,65.0,>50-75,2.0,1.68,>1.50-1.75,3.0,1120.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-15,104.0,2012-04-04,2012-04-04,2012-10-01,Died,2.0,2.0,0.3942505133470226,<=3,1.0,0.3942505133470226,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N1,60,51-60,6.0
CO-101-001,CO-101-001-051-002,01051002,051,68.0,YEARS,61-70,3.0,>=65,2.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,182.0,>175,6.0,80.0,>75-100,3.0,2.01,>2.0,5.0,28.8,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,SUBDURAL HEMATOMA,Y,SUBDURAL HEMATOMA,2012-04-13,408.0,2012-03-23,,2012-10-01,Died,2.0,2.0,2.299794661190965,<=3,1.0,2.102669404517454,<=3,1.0,0.2299794661190965,Y,Y,1.0,1,1.0,,Y,,,,,,G1 - Well differentiated,HEAD OF PANCREAS,T3,N1,30,21-30,3.0
CO-101-001,CO-101-001-051-003,01051003,051,69.0,YEARS,61-70,3.0,>=65,2.0,M,OTHER,99.0,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,170.0,>150-175,5.0,60.0,>50-75,2.0,1.69,>1.50-1.75,3.0,720.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-24,96.0,2011-07-05,2011-07-24,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.9856262833675564,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T2,N1,90,81-90,9.0
CO-101-001,CO-101-001-052-002,01052002,052,71.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,184.0,>175,6.0,92.4,>75-100,3.0,2.15,>2.0,5.0,2170.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-02,185.0,2011-09-26,2011-10-02,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.7885010266940452,<=3,1.0,0.2299794661190965,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T3,N1,40,31-40,4.0
CO-101-001,CO-101-001-052-003,01052003,052,43.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,184.0,>175,6.0,72.0,>50-75,2.0,1.94,>1.75-2.0,4.0,3.6,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,CAUSE UNKNOWN,2011-12-02,185.0,2011-08-10,,2012-10-01,Died,2.0,1.0,2.2669404517453797,<=3,1.0,2.2669404517453797,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N0,0,0-10,1.0
CO-101-001,CO-101-001-052-004,01052004,052,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,164.0,>150-175,5.0,52.0,>50-75,2.0,1.55,>1.50-1.75,3.0,46200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-20,139.0,2011-12-01,,2012-10-01,Died,2.0,3.0,1.5770020533880904,<=3,1.0,1.6427104722792607,<=3,1.0,-0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,TAIL OF PANCREAS,T3,N0,15,11-20,2.0
CO-101-001,CO-101-001-052-007,01052007,052,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,184.0,>175,6.0,76.0,>75-100,3.0,1.99,>1.75-2.0,4.0,455.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-04,75.0,2012-04-30,,2012-10-01,Died,2.0,3.0,0.7227926078028748,<=3,1.0,0.6899383983572895,<=3,1.0,0.06570841889117043,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N1,85,81-90,9.0
CO-101-001,CO-101-001-053-001,01053001,053,69.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,180.0,>175,6.0,90.0,>75-100,3.0,2.0,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,OTHER,8.0,WORSENING OF GENERAL HEALTH,Y,DISEASE PROGRESSION,2011-10-12,154.0,2011-11-08,2011-10-14,2012-10-01,Died,2.0,2.0,0.7885010266940452,<=3,1.0,0.7885010266940452,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-053-002,01053002,053,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,181.0,>175,6.0,67.5,>50-75,2.0,1.86,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,CAUSE UNKNOWN,2012-10-22,327.0,2012-09-17,2012-10-22,2012-10-01,Died,2.0,2.0,4.008213552361396,>3-6,2.0,3.4496919917864477,>3-6,2.0,0.5913757700205339,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,HEAD OF PANCREAS,Unknown,N1,70,61-70,7.0
CO-101-001,CO-101-001-054-001,01054001,054,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,183.0,>175,6.0,55.0,>50-75,2.0,1.72,>1.50-1.75,3.0,41600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,PULMONARY EMBOLISM,Y,PULMONARY EMBOLISM,2011-02-12,60.0,2011-02-12,,2012-10-01,Died,2.0,2.0,1.5770020533880904,<=3,1.0,0.8542094455852156,<=3,1.0,0.75564681724846,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,Tx,Nx,10,0-10,1.0
CO-101-001,CO-101-001-054-003,01054003,054,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,170.0,>150-175,5.0,72.0,>50-75,2.0,1.92,>1.75-2.0,4.0,6200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-03,385.0,2011-12-12,2012-01-23,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.9856262833675564,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,OTHER,Tx,Nx,20,11-20,2.0
CO-101-001,CO-101-001-054-005,01054005,054,49.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,164.0,>150-175,5.0,72.0,>50-75,2.0,1.78,>1.75-2.0,4.0,1450.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-22,2012-10-22,2012-10-01,Alive,1.0,4.0,2.0698151950718686,<=3,1.0,0.459958932238193,<=3,1.0,1.6427104722792607,Y,Y,2.0,2,2.0,Y,,,Y,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,N0,70,61-70,7.0
CO-101-001,CO-101-001-054-006,01054006,054,40.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.0,>150-175,5.0,69.7,>50-75,2.0,1.74,>1.50-1.75,3.0,3010.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,OTHER,8.0,INVESTIGATOR DECISION,Y,DISEASE PROGRESSION,2011-10-08,216.0,2011-09-13,2011-10-08,2012-10-01,Died,2.0,12.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,Y,Y,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Tx,Nx,0,0-10,1.0
CO-101-001,CO-101-001-054-007,01054007,054,68.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,166.0,>150-175,5.0,72.8,>50-75,2.0,1.81,>1.75-2.0,4.0,26.8,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-05-25,344.0,2012-05-04,2012-05-25,2012-10-01,Died,2.0,2.0,35.5482546201232,>24,5.0,0.75564681724846,<=3,1.0,34.82546201232033,Y,Y,2.0,2,2.0,,Y,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N0,30,21-30,3.0
CO-101-001,CO-101-001-054-009,01054009,054,57.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,168.0,>150-175,5.0,60.0,>50-75,2.0,1.68,>1.50-1.75,3.0,3150.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,,,,,2012-10-17,2012-10-17,2012-10-01,Alive,1.0,3.0,1.7741273100616017,<=3,1.0,1.379876796714579,<=3,1.0,0.4271047227926078,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,10,0-10,1.0
CO-101-001,CO-101-001-054-010,01054010,054,52.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,186.0,>175,6.0,95.0,>75-100,3.0,2.2,>2.0,5.0,60000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-27,50.0,2012-01-25,2012-01-27,2012-10-01,Died,2.0,3.0,1.3470225872689938,<=3,1.0,0.459958932238193,<=3,1.0,0.919917864476386,Y,Y,4.0,4,4.0,Y,,Y,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-054-011,01054011,054,57.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,165.0,>150-175,5.0,58.0,>50-75,2.0,1.64,>1.50-1.75,3.0,1190.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-11-01,2012-11-01,2012-10-01,Alive,1.0,3.0,34.46406570841889,>24,5.0,0.6570841889117043,<=3,1.0,33.83983572895277,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T0,N0,15,11-20,2.0
CO-101-001,CO-101-001-054-012,01054012,054,76.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,158.0,>150-175,5.0,73.0,>50-75,2.0,1.75,>1.50-1.75,3.0,47600.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-21,100.0,2012-04-20,2012-04-21,2012-10-01,Died,2.0,3.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,Tx,Nx,10,0-10,1.0
CO-101-001,CO-101-001-054-015,01054015,054,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,DEU,GERMANY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,,,,,,,,,,,,,N,Y,Y,N,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,,,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-06-11,,2012-06-05,2012-08-17,2012-10-01,Died,2.0,,1.9055441478439425,<=3,1.0,1.9055441478439425,<=3,1.0,0.03285420944558522,N,Y,1.0,1,1.0,,,,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,Tx,Nx,20,11-20,2.0
CO-101-001,CO-101-001-055-001,01055001,055,72.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,174.0,>150-175,5.0,80.1,>75-100,3.0,1.94,>1.75-2.0,4.0,1800.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-12,465.0,2011-10-26,2011-10-26,2012-10-01,Died,2.0,1.0,0.5585215605749486,<=3,1.0,0.5585215605749486,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T3,N0,50,41-50,5.0
CO-101-001,CO-101-001-055-004,01055004,055,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,160.0,>150-175,5.0,72.5,>50-75,2.0,1.74,>1.50-1.75,3.0,9.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2010-12-30,113.0,2010-11-18,,2012-10-01,Died,2.0,2.0,0.75564681724846,<=3,1.0,0.75564681724846,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,T3,N0,20,11-20,2.0
CO-101-001,CO-101-001-055-005,01055005,055,37.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,166.0,>150-175,5.0,51.1,>50-75,2.0,1.54,>1.50-1.75,3.0,1240.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-02-08,132.0,2011-01-31,2011-01-31,2012-10-01,Died,2.0,3.0,0.8213552361396304,<=3,1.0,0.8213552361396304,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,Unknown,HEAD OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-055-006,01055006,055,43.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,183.0,>175,6.0,84.3,>75-100,3.0,2.06,>2.0,5.0,0.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,4.0,2.595482546201232,<=3,1.0,0.4271047227926078,<=3,1.0,2.2012320328542097,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T3,Nx,40,31-40,4.0
CO-101-001,CO-101-001-055-008,01055008,055,48.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,158.5,>150-175,5.0,53.0,>50-75,2.0,1.52,>1.50-1.75,3.0,188000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-28,101.0,2011-05-12,2011-05-12,2012-10-01,Died,2.0,2.0,0.8870636550308009,<=3,1.0,0.8870636550308009,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,TAIL OF PANCREAS,T4,N0,20,11-20,2.0
CO-101-001,CO-101-001-055-010,01055010,055,70.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,171.0,>150-175,5.0,83.0,>75-100,3.0,1.96,>1.75-2.0,4.0,2070.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-08,211.0,2011-11-24,2011-11-24,2012-10-01,Died,2.0,4.0,0.8870636550308009,<=3,1.0,0.8870636550308009,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,Unknown,100,91-100,10.0
CO-101-001,CO-101-001-056-001,01056001,056,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,196.0,>175,6.0,103.0,>100-125,4.0,2.4,>2.0,5.0,492000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,CEREBRAL STROKE,2011-09-22,148.0,2011-08-31,2011-08-31,2012-10-01,Died,2.0,3.0,1.3141683778234086,<=3,1.0,1.3141683778234086,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,TAIL OF PANCREAS,T3,Nx,40,31-40,4.0
CO-101-001,CO-101-001-056-002,01056002,056,79.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,186.0,>175,6.0,84.0,>75-100,3.0,2.08,>2.0,5.0,87100.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,CAUSE UNKNOWN,2011-09-19,124.0,2011-06-13,,2012-10-01,Died,2.0,3.0,1.3470225872689938,<=3,1.0,1.3470225872689938,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T3,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-056-003,01056003,056,56.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,160.0,>150-175,5.0,54.0,>50-75,2.0,1.55,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-23,163.0,2012-07-31,2011-11-21,2012-10-01,Died,2.0,3.0,1.8726899383983573,<=3,1.0,1.8726899383983573,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,,Y,G1 - Well differentiated,TAIL OF PANCREAS,T3,N0,30,21-30,3.0
CO-101-001,CO-101-001-059-003,01059003,059,71.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,164.0,>150-175,5.0,63.0,>50-75,2.0,1.68,>1.50-1.75,3.0,101000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-07,125.0,2012-02-20,2012-02-20,2012-10-01,Died,2.0,3.0,2.135523613963039,<=3,1.0,2.135523613963039,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,Tx,N1,10,0-10,1.0
CO-101-001,CO-101-001-060-002,01060002,060,77.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,172.0,>150-175,5.0,72.0,>50-75,2.0,1.83,>1.75-2.0,4.0,55.1,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,TOXICITY DUE TO CURRENT CHEMOTHERAPY (CAPECITABINE),2012-04-03,348.0,2012-03-14,2012-03-14,2012-10-01,Died,2.0,2.0,2.0698151950718686,<=3,1.0,1.051334702258727,<=3,1.0,1.051334702258727,Y,Y,2.0,2,2.0,,Y,,Y,,,,Unknown,HEAD OF PANCREAS,T4,N1,7,0-10,1.0
CO-101-001,CO-101-001-060-003,01060003,060,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,173.5,>150-175,5.0,87.5,>75-100,3.0,2.0,>1.75-2.0,4.0,1050.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-15,164.0,2011-09-08,2011-10-15,2012-10-01,Died,2.0,1.0,0.9527720739219713,<=3,1.0,0.5585215605749486,<=3,1.0,0.4271047227926078,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N0,60,51-60,6.0
CO-101-001,CO-101-001-060-005,01060005,060,66.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,148.0,>125-150,4.0,39.5,<=50,1.0,1.26,>1.25-1.50,2.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-07-14,367.0,2012-07-03,2012-07-03,2012-10-01,Died,2.0,2.0,1.1827515400410678,<=3,1.0,0.75564681724846,<=3,1.0,0.459958932238193,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-060-007,01060007,060,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,147.0,>125-150,4.0,40.2,<=50,1.0,1.27,>1.25-1.50,2.0,965000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-24,174.0,2012-02-24,2012-03-28,2012-10-01,Died,2.0,4.0,1.2484599589322383,<=3,1.0,0.8213552361396304,<=3,1.0,0.459958932238193,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,BODY OF PANCREAS,T4,N0,40,31-40,4.0
CO-101-001,CO-101-001-060-008,01060008,060,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,154.5,>150-175,5.0,45.5,<=50,1.0,1.38,>1.25-1.50,2.0,819.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,DEATH,2.0,PERITONITIS,Y,PERITONITIS,2011-10-30,10.0,2011-10-21,,2012-10-01,Died,2.0,3.0,2.299794661190965,<=3,1.0,0.8870636550308009,<=3,1.0,1.4455852156057496,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,OTHER,T3,N1,90,81-90,9.0
CO-101-001,CO-101-001-060-009,01060009,060,77.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,151.0,>150-175,5.0,51.0,>50-75,2.0,1.46,>1.25-1.50,2.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-11,118.0,2012-06-08,2012-06-08,2012-10-01,Died,2.0,2.0,0.4928131416837782,<=3,1.0,0.4928131416837782,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,Tx,Nx,50,41-50,5.0
CO-101-001,CO-101-001-060-010,01060010,060,82.0,YEARS,81-90,5.0,>=65,2.0,F,WHITE,5.0,ITA,ITALY,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,151.0,>150-175,5.0,59.0,>50-75,2.0,1.53,>1.50-1.75,3.0,4390.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,,,,,2012-10-10,2012-10-10,2012-10-01,Alive,1.0,2.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,Tx,Nx,80,71-80,8.0
CO-101-001,CO-101-001-062-001,01062001,062,71.0,YEARS,71-80,4.0,>=65,2.0,F,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.5,>150-175,5.0,58.2,>50-75,2.0,1.6,>1.50-1.75,3.0,28700.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-29,21.0,2011-05-09,2011-06-23,2012-10-01,Died,2.0,7.0,1.5770020533880904,<=3,1.0,1.5441478439425051,<=3,1.0,0.06570841889117043,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,Tx,N0,70,61-70,7.0
CO-101-001,CO-101-001-062-003,01062003,062,78.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,175.5,>175,6.0,57.0,>50-75,2.0,1.7,>1.50-1.75,3.0,3850.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,CLINICAL DETERIORATION,2011-11-07,77.0,2011-11-01,2011-11-01,2012-10-01,Died,2.0,2.0,0.8213552361396304,<=3,1.0,0.8213552361396304,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T4,N0,70,61-70,7.0
CO-101-001,CO-101-001-062-004,01062004,062,59.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,173.4,>150-175,5.0,64.9,>50-75,2.0,1.78,>1.75-2.0,4.0,65200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-04-13,157.0,2012-04-06,2012-04-06,2012-10-01,Died,2.0,1.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N1,5,0-10,1.0
CO-101-001,CO-101-001-062-005,01062005,062,75.0,YEARS,71-80,4.0,>=65,2.0,F,OTHER,99.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,159.4,>150-175,5.0,46.3,<=50,1.0,1.44,>1.25-1.50,2.0,13400.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,,,,,,,,2012-10-22,,2012-10-01,,,4.0,3.5811088295687883,>3-6,2.0,0.7227926078028748,<=3,1.0,2.891170431211499,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N0,98,91-100,10.0
CO-101-001,CO-101-001-062-006,01062006,062,41.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,177.0,>175,6.0,104.0,>100-125,4.0,2.18,>2.0,5.0,17200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,PULMONARY FIBROSIS AND DEATH PROGRESSION,2012-07-02,218.0,2012-05-28,,2012-10-01,Died,2.0,4.0,1.2484599589322383,<=3,1.0,1.2484599589322383,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-062-007,01062007,062,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,166.0,>150-175,5.0,54.3,>50-75,2.0,1.61,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,OTHER,8.0,PATIENT WISHED TO CONTINUE TREATMENT AT LOCAL HOSPITAL AS SHE HAD BEEN RANDOMISED TO STANDARD TREATMENT.,Y,DISEASE PROGRESSION,2012-04-30,106.0,2012-03-30,2012-03-30,2012-10-01,Died,2.0,4.0,0.32854209445585214,<=3,1.0,0.32854209445585214,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,Unknown,90,81-90,9.0
CO-101-001,CO-101-001-062-009,01062009,062,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,177.4,>175,6.0,58.5,>50-75,2.0,1.71,>1.50-1.75,3.0,965.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-09-05,218.0,2012-08-13,2012-08-13,2012-10-01,Died,2.0,2.0,1.1170431211498972,<=3,1.0,0.2299794661190965,<=3,1.0,0.919917864476386,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G4 - Undifferentiated,HEAD OF PANCREAS,T4,N0,0,0-10,1.0
CO-101-001,CO-101-001-062-010,01062010,062,63.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,181.0,>175,6.0,75.4,>75-100,3.0,1.97,>1.75-2.0,4.0,12100.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,CAUSE UNKNOWN,2012,,2012-04-20,2012-04-20,2012-10-01,Died,2.0,3.0,1.5770020533880904,<=3,1.0,0.4271047227926078,<=3,1.0,1.1827515400410678,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,Unknown,70,61-70,7.0
CO-101-001,CO-101-001-062-012,01062012,062,60.0,YEARS,51-60,2.0,<65,1.0,M,ASIAN,2.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,174.0,>150-175,5.0,61.4,>50-75,2.0,1.72,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROTOCOL VIOLATION,4.0,PROTOCOL VIOLATION,,,,,2012-10-10,2012-10-10,2012-10-01,Alive,1.0,4.0,29.60164271047228,>24,5.0,0.16427104722792607,<=3,1.0,29.470225872689937,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N1,10,0-10,1.0
CO-101-001,CO-101-001-062-013,01062013,062,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,GBR,UNITED KINGDOM,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,180.4,>175,6.0,78.5,>75-100,3.0,1.97,>1.75-2.0,4.0,965000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,CEREBRAL VASCULAR EVENT AND PNEUMONIA,2012-03-26,27.0,2012-03-13,,2012-10-01,Died,2.0,2.0,0.4271047227926078,<=3,1.0,0.4271047227926078,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,Unknown,BODY OF PANCREAS,T4,N1,45,41-50,5.0
CO-101-001,CO-101-001-063-002,01063002,063,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,172.7,>150-175,5.0,51.3,>50-75,2.0,1.6,>1.50-1.75,3.0,109000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,METASTATIC PANCREATIC ADENOCARCINOMA,2011-08-28,88.0,2011-08-24,2011-08-29,2012-10-01,Died,2.0,3.0,0.8542094455852156,<=3,1.0,0.8542094455852156,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,OTHER,T4,N1,30,21-30,3.0
CO-101-001,CO-101-001-063-003,01063003,063,69.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,180.3,>175,6.0,83.9,>75-100,3.0,2.0,>1.75-2.0,4.0,18300.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-01-14,37.0,2012-01-12,2012-01-16,2012-10-01,Died,2.0,1.0,0.7885010266940452,<=3,1.0,0.7885010266940452,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,Y,,Y,,Y,Y,Unknown,TAIL OF PANCREAS,T4,N1,70,61-70,7.0
CO-101-001,CO-101-001-064-001,01064001,064,76.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,157.5,>150-175,5.0,57.5,>50-75,2.0,1.58,>1.50-1.75,3.0,78.8,>2xULN-3xULN,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,OTHER,8.0,PATIENT DISCHARGE FROM HOSPITAL TO HOSPICE,Y,CAUSE UNKNOWN,2012-02-13,511.0,2012-01-18,2012-02-13,2012-10-01,Died,2.0,2.0,1.3470225872689938,<=3,1.0,0.6899383983572895,<=3,1.0,0.6899383983572895,Y,Y,1.0,1,1.0,,Y,,,,,,G1 - Well differentiated,TAIL OF PANCREAS,Unknown,Unknown,40,31-40,4.0
CO-101-001,CO-101-001-064-003,01064003,064,60.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,165.1,>150-175,5.0,74.4,>50-75,2.0,1.82,>1.75-2.0,4.0,35900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,METASTATIC PANCREATIC ADENOCARCINOMA,2011-09-06,303.0,2011-08-01,2011-08-01,2012-10-01,Died,2.0,4.0,0.3942505133470226,<=3,1.0,0.3942505133470226,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,,Y,Unknown,HEAD OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-064-004,01064004,064,80.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,160.5,>150-175,5.0,84.2,>75-100,3.0,1.88,>1.75-2.0,4.0,32600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,METASTATIC PANCREATIC ADENOCARCINOMA,Y,METASTATIC PANCREATIC ADENOCARCINOMA,2011-04-30,159.0,2011-04-26,,2012-10-01,Died,2.0,1.0,0.75564681724846,<=3,1.0,0.75564681724846,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-064-005,01064005,064,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,182.9,>175,6.0,126.2,>125-150,5.0,2.4,>2.0,5.0,263000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-01,300.0,2012-03-01,2012-04-01,2012-10-01,Died,2.0,2.0,0.5913757700205339,<=3,1.0,0.5913757700205339,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,TAIL OF PANCREAS,T3,,0,0-10,1.0
CO-101-001,CO-101-001-064-006,01064006,064,53.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.6,>150-175,5.0,89.8,>75-100,3.0,1.99,>1.75-2.0,4.0,1630.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-08,268.0,2012-04-23,2012-05-08,2012-10-01,Died,2.0,4.0,0.5913757700205339,<=3,1.0,0.5913757700205339,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T4,N1,20,11-20,2.0
CO-101-001,CO-101-001-065-002,01065002,065,59.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,83.0,>75-100,3.0,1.98,>1.75-2.0,4.0,23800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-27,122.0,2011-08-15,2011-08-30,2012-10-01,Died,2.0,1.0,1.9712525667351128,<=3,1.0,1.9712525667351128,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T3,Nx,10,0-10,1.0
CO-101-001,CO-101-001-065-003,01065003,065,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,156.0,>150-175,5.0,53.0,>50-75,2.0,1.52,>1.50-1.75,3.0,71.2,>ULN-2xULN,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-15,75.0,2011-08-03,2011-08-22,2012-10-01,Died,2.0,3.0,3.055441478439425,>3-6,2.0,1.6098562628336757,<=3,1.0,1.4784394250513346,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T3,Nx,90,81-90,9.0
CO-101-001,CO-101-001-065-004,01065004,065,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,73.0,>50-75,2.0,1.85,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,CAUSE UNKNOWN,2012-08-31,276.0,2012-08-03,2012-09-06,2012-10-01,Died,2.0,3.0,2.004106776180698,<=3,1.0,1.2813141683778233,<=3,1.0,0.75564681724846,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,Nx,10,0-10,1.0
CO-101-001,CO-101-001-066-003,01066003,066,65.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,60.0,>50-75,2.0,1.68,>1.50-1.75,3.0,10900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-03-31,95.0,2011-03-01,2011-04-01,2012-10-01,Died,2.0,4.0,0.5585215605749486,<=3,1.0,0.5585215605749486,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,Nx,90,81-90,9.0
CO-101-001,CO-101-001-066-005,01066005,066,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,160.0,>150-175,5.0,63.0,>50-75,2.0,1.67,>1.50-1.75,3.0,3370.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,STROKE,2012-01-16,208.0,2012-01-10,2012-01-20,2012-10-01,Died,2.0,1.0,16.229979466119097,>12-24,4.0,0.29568788501026694,<=3,1.0,15.967145790554415,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N0,70,61-70,7.0
CO-101-001,CO-101-001-066-006,01066006,066,39.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,182.0,>175,6.0,79.0,>75-100,3.0,1.99,>1.75-2.0,4.0,214000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-27,88.0,2011-11-24,2011-12-08,2012-10-01,Died,2.0,1.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,HEAD OF PANCREAS,Tx,Nx,0,0-10,1.0
CO-101-001,CO-101-001-066-007,01066007,066,62.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,147.0,>125-150,4.0,47.5,<=50,1.0,1.39,>1.25-1.50,2.0,4140.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-15,100.0,2011-11-28,2011-11-28,2012-10-01,Died,2.0,2.0,1.7741273100616017,<=3,1.0,0.8213552361396304,<=3,1.0,0.9856262833675564,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,Nx,5,0-10,1.0
CO-101-001,CO-101-001-066-008,01066008,066,63.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,70.0,>50-75,2.0,1.85,>1.75-2.0,4.0,148.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-08,170.0,2012-07-23,2012-08-24,2012-10-01,Died,2.0,2.0,0.7227926078028748,<=3,1.0,0.459958932238193,<=3,1.0,0.29568788501026694,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N0,30,21-30,3.0
CO-101-001,CO-101-001-066-009,01066009,066,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,167.0,>150-175,5.0,71.0,>50-75,2.0,1.81,>1.75-2.0,4.0,1480.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-25,2012-10-25,2012-10-01,Alive,1.0,1.0,1.051334702258727,<=3,1.0,1.051334702258727,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,35,31-40,4.0
CO-101-001,CO-101-001-066-010,01066010,066,50.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,51.7,>50-75,2.0,1.54,>1.50-1.75,3.0,777.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-17,133.0,2012-07-12,2012-08-15,2012-10-01,Died,2.0,2.0,6.4722792607802875,>6-12,3.0,1.4127310061601643,<=3,1.0,5.092402464065708,Y,Y,1.0,1,1.0,,,Y,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N0,35,31-40,4.0
CO-101-001,CO-101-001-066-011,01066011,066,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,75.0,>50-75,2.0,1.88,>1.75-2.0,4.0,450.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,,,,,,,,2012-10-17,,2012-10-01,,,2.0,1.1498973305954825,<=3,1.0,0.26283367556468173,<=3,1.0,0.919917864476386,Y,Y,1.0,1,1.0,Y,,,,,,,G1 - Well differentiated,OTHER,T3,Nx,100,91-100,10.0
CO-101-001,CO-101-001-067-001,01067001,067,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,62.0,>50-75,2.0,1.76,>1.75-2.0,4.0,1670.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-02-28,125.0,2011-02-15,2011-03-15,2012-10-01,Died,2.0,1.0,1.9383983572895278,<=3,1.0,1.9383983572895278,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T4,N1,98,91-100,10.0
CO-101-001,CO-101-001-067-002,01067002,067,26.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,52.0,>50-75,2.0,1.59,>1.50-1.75,3.0,29100.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-31,190.0,2011-05-16,2011-05-16,2012-10-01,Died,2.0,1.0,0.8542094455852156,<=3,1.0,0.8542094455852156,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,OTHER,T3,Nx,0,0-10,1.0
CO-101-001,CO-101-001-067-003,01067003,067,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,153.0,>150-175,5.0,57.0,>50-75,2.0,1.56,>1.50-1.75,3.0,1200.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-01,277.0,2011-08-18,2011-09-05,2012-10-01,Died,2.0,4.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,,Y,,,,Y,G1 - Well differentiated,BODY OF PANCREAS,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-067-004,01067004,067,53.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,90.0,>75-100,3.0,2.06,>2.0,5.0,272000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-27,379.0,2011-12-15,2012-01-11,2012-10-01,Died,2.0,1.0,1.051334702258727,<=3,1.0,1.051334702258727,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G4 - Undifferentiated,TAIL OF PANCREAS,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-067-005,01067005,067,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,177.0,>175,6.0,75.0,>50-75,2.0,1.92,>1.75-2.0,4.0,243.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-03,294.0,2011-09-07,2011-10-07,2012-10-01,Died,2.0,1.0,2.924024640657084,<=3,1.0,2.924024640657084,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,OTHER,T4,Nx,5,0-10,1.0
CO-101-001,CO-101-001-067-007,01067007,067,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,75.0,>50-75,2.0,1.91,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-02-09,50.0,2011-02-01,,2012-10-01,Died,2.0,1.0,1.3470225872689938,<=3,1.0,0.8870636550308009,<=3,1.0,0.4928131416837782,Y,Y,2.0,2,2.0,Y,,Y,,,,,G3 - Poorly differentiated,OTHER,T4,Nx,30,21-30,3.0
CO-101-001,CO-101-001-067-008,01067008,067,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,79.0,>75-100,3.0,1.93,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-01-20,16.0,2011-01-18,,2012-10-01,Died,2.0,1.0,1.4784394250513346,<=3,1.0,1.4784394250513346,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,Nx,50,41-50,5.0
CO-101-001,CO-101-001-067-009,01067009,067,47.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,173.0,>150-175,5.0,82.0,>75-100,3.0,1.98,>1.75-2.0,4.0,197000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROTOCOL VIOLATION,4.0,PROTOCOL VIOLATION,Y,DISEASE PROGRESSION,2011-04-23,62.0,2011-03-15,,2012-10-01,Died,2.0,1.0,2.5626283367556466,<=3,1.0,2.5626283367556466,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,T3,Nx,10,0-10,1.0
CO-101-001,CO-101-001-067-010,01067010,067,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,79.0,>75-100,3.0,1.98,>1.75-2.0,4.0,66.4,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-11,24.0,2011-04-26,,2012-10-01,Died,2.0,4.0,2.924024640657084,<=3,1.0,2.924024640657084,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,OTHER,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-067-011,01067011,067,58.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,62.0,>50-75,2.0,1.74,>1.50-1.75,3.0,7.2,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,,,,,2012-10-26,2012-10-26,2012-10-01,Alive,1.0,4.0,7.392197125256674,>6-12,3.0,7.030800821355236,>6-12,3.0,0.3942505133470226,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T4,N0,1,0-10,1.0
CO-101-001,CO-101-001-067-012,01067012,067,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,75.0,>50-75,2.0,1.87,>1.75-2.0,4.0,500.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-26,90.0,2011-07-21,,2012-10-01,Died,2.0,1.0,3.482546201232033,>3-6,2.0,1.4784394250513346,<=3,1.0,2.0369609856262834,Y,Y,2.0,2,2.0,Y,,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,Nx,15,11-20,2.0
CO-101-001,CO-101-001-067-013,01067013,067,57.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,95.0,>75-100,3.0,2.06,>2.0,5.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-14,461.0,2012-08-06,2012-09-06,2012-10-01,Died,2.0,2.0,0.9527720739219713,<=3,1.0,0.8870636550308009,<=3,1.0,0.09856262833675565,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,Nx,50,41-50,5.0
CO-101-001,CO-101-001-067-014,01067014,067,69.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,163.0,>150-175,5.0,60.0,>50-75,2.0,1.65,>1.50-1.75,3.0,43.8,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,PULMONARY ARTERY THROMBOEMBOLISM,Y,PULMONARY ARTERY THROMBOEMBOLISM,2011-05-30,19.0,2011-05-26,,2012-10-01,Died,2.0,2.0,0.8870636550308009,<=3,1.0,0.6570841889117043,<=3,1.0,0.26283367556468173,Y,Y,4.0,4,4.0,Y,Y,Y,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,Nx,5,0-10,1.0
CO-101-001,CO-101-001-067-015,01067015,067,62.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,175.0,>150-175,5.0,71.0,>50-75,2.0,1.86,>1.75-2.0,4.0,686.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-18,127.0,2011-10-06,,2012-10-01,Died,2.0,1.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,Nx,30,21-30,3.0
CO-101-001,CO-101-001-067-016,01067016,067,62.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,72.0,>50-75,2.0,1.84,>1.75-2.0,4.0,5490.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-03,197.0,2011-12-06,,2012-10-01,Died,2.0,2.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,OTHER,T4,Nx,5,0-10,1.0
CO-101-001,CO-101-001-067-019,01067019,067,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,183.0,>175,6.0,97.0,>75-100,3.0,2.24,>2.0,5.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-10,101.0,2011-11-08,,2012-10-01,Died,2.0,1.0,1.1170431211498972,<=3,1.0,1.1170431211498972,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,Nx,5,0-10,1.0
CO-101-001,CO-101-001-067-020,01067020,067,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,56.0,>50-75,2.0,1.62,>1.50-1.75,3.0,19000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-15,260.0,2012-04-11,2012-05-19,2012-10-01,Died,2.0,2.0,1.8069815195071868,<=3,1.0,1.8069815195071868,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,OTHER,T4,N1,20,11-20,2.0
CO-101-001,CO-101-001-067-021,01067021,067,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,164.0,>150-175,5.0,77.0,>75-100,3.0,1.87,>1.75-2.0,4.0,1710.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-27,2012-10-27,2012-10-01,Alive,1.0,2.0,0.4271047227926078,<=3,1.0,0.4271047227926078,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,,Y,,,,,,Unknown,HEAD OF PANCREAS,T4,N1,10,0-10,1.0
CO-101-001,CO-101-001-067-022,01067022,067,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,44.1,<=50,1.0,1.4,>1.25-1.50,2.0,29.5,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-06-04,2012-06-04,2012-10-01,Lost to Follow-up,3.0,2.0,1.4455852156057496,<=3,1.0,1.4455852156057496,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N1,10,0-10,1.0
CO-101-001,CO-101-001-067-023,01067023,067,68.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,152.0,>150-175,5.0,69.7,>50-75,2.0,1.72,>1.50-1.75,3.0,2420.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,1.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,,Y,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T3,Unknown,10,0-10,1.0
CO-101-001,CO-101-001-067-024,01067024,067,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,52.0,>50-75,2.0,1.51,>1.50-1.75,3.0,37600.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,DEATH,2.0,CAUSE UNKNOWN,Y,CAUSE UNKNOWN,2012-01-03,9.0,2011-12-26,,2012-10-01,Died,2.0,1.0,1.7741273100616017,<=3,1.0,1.051334702258727,<=3,1.0,0.75564681724846,Y,Y,2.0,2,2.0,Y,,,,,,Y,G3 - Poorly differentiated,OTHER,T2,Nx,50,41-50,5.0
CO-101-001,CO-101-001-067-026,01067026,067,55.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,154.0,>150-175,5.0,66.0,>50-75,2.0,1.68,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-25,2012-10-25,2012-10-01,Alive,1.0,1.0,0.8870636550308009,<=3,1.0,0.8542094455852156,<=3,1.0,0.06570841889117043,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,50,41-50,5.0
CO-101-001,CO-101-001-067-027,01067027,067,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,55.0,>50-75,2.0,1.55,>1.50-1.75,3.0,23600.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-24,26.0,2012-02-21,,2012-10-01,Died,2.0,1.0,1.1498973305954825,<=3,1.0,1.1498973305954825,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,Y,,,,,Y,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-068-001,01068001,068,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,146.0,>125-150,4.0,51.0,>50-75,2.0,1.44,>1.25-1.50,2.0,2710.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-13,117.0,2011-04-28,2011-05-27,2012-10-01,Died,2.0,4.0,1.4784394250513346,<=3,1.0,1.0184804928131417,<=3,1.0,0.4928131416837782,Y,Y,2.0,2,2.0,,Y,Y,,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,T3,N1,90,81-90,9.0
CO-101-001,CO-101-001-068-002,01068002,068,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,58.0,>50-75,2.0,1.62,>1.50-1.75,3.0,1930.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-18,427.0,2012-02-19,2012-04-06,2012-10-01,Died,2.0,4.0,1.3141683778234086,<=3,1.0,0.8542094455852156,<=3,1.0,0.4928131416837782,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,GX - Grade cannot be assessed,BODY OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-069-001,01069001,069,51.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,183.0,>175,6.0,94.0,>75-100,3.0,2.19,>2.0,5.0,1130.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-15,212.0,2011-09-01,2011-09-28,2012-10-01,Died,2.0,2.0,1.379876796714579,<=3,1.0,0.9856262833675564,<=3,1.0,0.4271047227926078,Y,Y,2.0,2,2.0,Y,Y,,,,,,G4 - Undifferentiated,HEAD OF PANCREAS,T1,Nx,60,51-60,6.0
CO-101-001,CO-101-001-069-002,01069002,069,46.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,67.0,>50-75,2.0,1.82,>1.75-2.0,4.0,1390.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-06,189.0,2011-08-17,2011-09-14,2012-10-01,Died,2.0,2.0,2.3655030800821355,<=3,1.0,1.3470225872689938,<=3,1.0,1.051334702258727,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,Nx,70,61-70,7.0
CO-101-001,CO-101-001-069-003,01069003,069,52.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,62.0,>50-75,2.0,1.65,>1.50-1.75,3.0,99.3,>2xULN-3xULN,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-12,169.0,2011-09-28,2011-10-26,2012-10-01,Died,2.0,2.0,0.6242299794661191,<=3,1.0,0.6242299794661191,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,T1,Nx,70,61-70,7.0
CO-101-001,CO-101-001-069-004,01069004,069,51.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,179.0,>175,6.0,80.0,>75-100,3.0,1.99,>1.75-2.0,4.0,17.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-31,111.0,2011-10-05,2011-11-02,2012-10-01,Died,2.0,1.0,2.135523613963039,<=3,1.0,0.6570841889117043,<=3,1.0,1.51129363449692,Y,Y,2.0,2,2.0,,Y,Y,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,Nx,80,71-80,8.0
CO-101-001,CO-101-001-069-005,01069005,069,53.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,48.0,<=50,1.0,1.47,>1.25-1.50,2.0,17600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,DEATH,2.0,GASTROINTESTINAL HEMORRAGE,Y,GASTROINTESTINAL HEMORRAGE,2011-10-03,35.0,2011-09-27,,2012-10-01,Died,2.0,5.0,4.041067761806982,>3-6,2.0,1.7741273100616017,<=3,1.0,2.299794661190965,Y,Y,2.0,2,2.0,Y,,,,,,Y,GX - Grade cannot be assessed,HEAD OF PANCREAS,T3,Nx,60,51-60,6.0
CO-101-001,CO-101-001-070-003,01070003,070,68.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,160.0,>150-175,5.0,55.0,>50-75,2.0,1.56,>1.50-1.75,3.0,35.6,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-06-10,122.0,2011-05-05,2011-06-17,2012-10-01,Died,2.0,1.0,3.646817248459959,>3-6,2.0,3.646817248459959,>3-6,2.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,Y,Y,,,,Unknown,OTHER,T3,Nx,95,91-100,10.0
CO-101-001,CO-101-001-070-004,01070004,070,58.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,80.0,>75-100,3.0,1.9,>1.75-2.0,4.0,3980.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROTOCOL VIOLATION,4.0,PROTOCOL VIOLATION,Y,DISEASE PROGRESSION,2011-05-07,90.0,2011-04-27,2011-06-07,2012-10-01,Died,2.0,1.0,1.3470225872689938,<=3,1.0,1.3470225872689938,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,Tx,Nx,5,0-10,1.0
CO-101-001,CO-101-001-070-006,01070006,070,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,170.0,>150-175,5.0,112.0,>100-125,4.0,2.0,>1.75-2.0,4.0,3860.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-16,275.0,2011-11-08,2011-12-06,2012-10-01,Died,2.0,2.0,1.51129363449692,<=3,1.0,0.7227926078028748,<=3,1.0,0.8213552361396304,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T2,N0,10,0-10,1.0
CO-101-001,CO-101-001-070-007,01070007,070,72.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,160.0,>150-175,5.0,70.0,>50-75,2.0,1.76,>1.75-2.0,4.0,636.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-29,194.0,2011-08-19,2011-08-19,2012-10-01,Died,2.0,3.0,2.529774127310062,<=3,1.0,0.5256673511293635,<=3,1.0,2.0369609856262834,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,BODY OF PANCREAS,Tx,Nx,0,0-10,1.0
CO-101-001,CO-101-001-070-011,01070011,070,48.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,175.0,>150-175,5.0,59.0,>50-75,2.0,1.7,>1.50-1.75,3.0,47.0,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-06-12,80.0,2011-05-19,2011-06-24,2012-10-01,Died,2.0,2.0,3.1211498973305956,>3-6,2.0,1.215605749486653,<=3,1.0,1.9383983572895278,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T4,Nx,100,91-100,10.0
CO-101-001,CO-101-001-070-012,01070012,070,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,172.0,>150-175,5.0,60.0,>50-75,2.0,1.7,>1.50-1.75,3.0,3.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-17,27.0,2011-05-05,2011-05-30,2012-10-01,Died,2.0,1.0,1.379876796714579,<=3,1.0,1.379876796714579,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,Y,,,,Y,Unknown,BODY OF PANCREAS,T3,Nx,30,21-30,3.0
CO-101-001,CO-101-001-070-014,01070014,070,32.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,58.0,>50-75,2.0,1.7,>1.50-1.75,3.0,43200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-30,338.0,2012-03-13,2012-03-13,2012-10-01,Died,2.0,1.0,1.9383983572895278,<=3,1.0,0.7227926078028748,<=3,1.0,1.2484599589322383,Y,Y,3.0,3,3.0,Y,,Y,Y,,,,Unknown,TAIL OF PANCREAS,T3,N0,40,31-40,4.0
CO-101-001,CO-101-001-070-015,01070015,070,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,181.0,>175,6.0,80.0,>75-100,3.0,2.0,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-15,201.0,2011-11-08,2011-11-17,2012-10-01,Died,2.0,1.0,0.8213552361396304,<=3,1.0,0.8213552361396304,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,Y,,,,Y,Unknown,BODY OF PANCREAS,T3,Unknown,10,0-10,1.0
CO-101-001,CO-101-001-070-017,01070017,070,42.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,72.0,>50-75,2.0,1.8,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-15,383.0,2012-05-03,2012-06-04,2012-10-01,Died,2.0,1.0,2.891170431211499,<=3,1.0,1.215605749486653,<=3,1.0,1.7084188911704312,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,Unknown,HEAD OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-070-021,01070021,070,74.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,160.0,>150-175,5.0,94.0,>75-100,3.0,2.0,>1.75-2.0,4.0,1950.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-12,57.0,2011-07-20,2011-08-16,2012-10-01,Died,2.0,1.0,0.7227926078028748,<=3,1.0,0.9856262833675564,<=3,1.0,-0.2299794661190965,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,HEAD OF PANCREAS,T4,N1,90,81-90,9.0
CO-101-001,CO-101-001-070-022,01070022,070,52.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,70.0,>50-75,2.0,1.85,>1.75-2.0,4.0,9350.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-09,143.0,2011-11-07,2011-12-07,2012-10-01,Died,2.0,1.0,0.919917864476386,<=3,1.0,0.6570841889117043,<=3,1.0,0.29568788501026694,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,BODY OF PANCREAS,T3,Nx,30,21-30,3.0
CO-101-001,CO-101-001-070-023,01070023,070,50.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,92.0,>75-100,3.0,2.0,>1.75-2.0,4.0,13.9,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-29,258.0,2012-02-06,2012-03-05,2012-10-01,Died,2.0,1.0,0.5585215605749486,<=3,1.0,1.5770020533880904,<=3,1.0,-0.9856262833675564,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,OTHER,T3,Nx,0,0-10,1.0
CO-101-001,CO-101-001-070-024,01070024,070,78.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,71.0,>50-75,2.0,1.82,>1.75-2.0,4.0,38900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-09,201.0,2012-02-15,2012-04-05,2012-10-01,Died,2.0,1.0,0.6242299794661191,<=3,1.0,0.6242299794661191,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,BODY OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-070-025,01070025,070,50.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,175.0,>150-175,5.0,114.0,>100-125,4.0,2.35,>2.0,5.0,556000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,OTHER,8.0,BAD GENERAL CONDITION.,Y,DISEASE PROGRESSION,2012-03-01,191.0,2012-02-02,2012-03-05,2012-10-01,Died,2.0,1.0,1.3470225872689938,<=3,1.0,0.5585215605749486,<=3,1.0,0.8213552361396304,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,TAIL OF PANCREAS,T3,N1,5,0-10,1.0
CO-101-001,CO-101-001-070-026,01070026,070,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,62.0,>50-75,2.0,1.77,>1.75-2.0,4.0,240000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-06,275.0,2012-04-05,2012-04-05,2012-10-01,Died,2.0,1.0,1.9055441478439425,<=3,1.0,1.9055441478439425,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,TAIL OF PANCREAS,T3,Nx,95,91-100,10.0
CO-101-001,CO-101-001-070-027,01070027,070,78.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,78.0,>75-100,3.0,1.94,>1.75-2.0,4.0,873.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-09,111.0,2011-12-07,2012-01-20,2012-10-01,Died,2.0,2.0,2.299794661190965,<=3,1.0,1.0841889117043122,<=3,1.0,1.2484599589322383,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,TAIL OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-070-029,01070029,070,49.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,59.0,>50-75,2.0,1.68,>1.50-1.75,3.0,11700.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-09,137.0,2012-02-03,2012-09-11,2012-10-01,Died,2.0,1.0,3.8439425051334704,>3-6,2.0,3.154004106776181,>3-6,2.0,0.7227926078028748,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,HEAD OF PANCREAS,T4,N1,95,91-100,10.0
CO-101-001,CO-101-001-070-030,01070030,070,60.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,168.0,>150-175,5.0,115.0,>100-125,4.0,2.3,>2.0,5.0,2860.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-05,121.0,2012-03-06,2012-03-06,2012-10-01,Died,2.0,2.0,0.6899383983572895,<=3,1.0,0.4928131416837782,<=3,1.0,0.2299794661190965,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,T2,Nx,100,91-100,10.0
CO-101-001,CO-101-001-070-033,01070033,070,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,183.0,>175,6.0,85.0,>75-100,3.0,2.07,>2.0,5.0,186.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,,,,,,,,2012-11-02,,2012-10-01,,,2.0,2.3983572895277208,<=3,1.0,1.051334702258727,<=3,1.0,1.379876796714579,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,T3,N0,70,61-70,7.0
CO-101-001,CO-101-001-070-035,01070035,070,46.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,56.0,>50-75,2.0,1.56,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-07,138.0,2012-06-25,2012-07-10,2012-10-01,Died,2.0,1.0,0.5256673511293635,<=3,1.0,0.5256673511293635,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,Unknown,HEAD OF PANCREAS,T1,N1,60,51-60,6.0
CO-101-001,CO-101-001-071-001,01071001,071,51.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,73.0,>50-75,2.0,1.81,>1.75-2.0,4.0,1650.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-04-13,150.0,2011-04-10,2011-05-10,2012-10-01,Died,2.0,1.0,1.3470225872689938,<=3,1.0,0.9527720739219713,<=3,1.0,0.4271047227926078,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N1,30,21-30,3.0
CO-101-001,CO-101-001-071-002,01071002,071,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,159.0,>150-175,5.0,54.0,>50-75,2.0,1.54,>1.50-1.75,3.0,969.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-16,578.0,2012-05-20,2012-06-28,2012-10-01,Died,2.0,1.0,1.5770020533880904,<=3,1.0,0.9856262833675564,<=3,1.0,0.6242299794661191,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,OTHER,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-071-003,01071003,071,50.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,70.0,>50-75,2.0,1.87,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-18,245.0,2011-08-11,2011-09-12,2012-10-01,Died,2.0,1.0,0.16427104722792607,<=3,1.0,0.9527720739219713,<=3,1.0,-0.75564681724846,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,OTHER,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-073-001,01073001,073,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,159.0,>150-175,5.0,54.0,>50-75,2.0,1.54,>1.50-1.75,3.0,44200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-04-07,80.0,2011-04-01,2011-04-29,2012-10-01,Died,2.0,2.0,0.9527720739219713,<=3,1.0,0.8213552361396304,<=3,1.0,0.16427104722792607,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,OTHER,T4,Nx,85,81-90,9.0
CO-101-001,CO-101-001-073-002,01073002,073,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,171.0,>150-175,5.0,55.0,>50-75,2.0,1.61,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-17,172.0,2011-06-23,,2012-10-01,Died,2.0,3.0,1.5770020533880904,<=3,1.0,0.9856262833675564,<=3,1.0,0.6242299794661191,Y,Y,4.0,4,4.0,,Y,Y,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N0,30,21-30,3.0
CO-101-001,CO-101-001-073-004,01073004,073,64.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,155.0,>150-175,5.0,45.0,<=50,1.0,1.4,>1.25-1.50,2.0,3030.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-24,130.0,2011-06-27,2011-07-27,2012-10-01,Died,2.0,3.0,3.909650924024641,>3-6,2.0,1.1827515400410678,<=3,1.0,2.759753593429158,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N1,30,21-30,3.0
CO-101-001,CO-101-001-073-005,01073005,073,70.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,154.0,>150-175,5.0,68.0,>50-75,2.0,1.7,>1.50-1.75,3.0,8370.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-19,203.0,2011-10-10,2011-11-11,2012-10-01,Died,2.0,3.0,2.0369609856262834,<=3,1.0,2.3655030800821355,<=3,1.0,-0.29568788501026694,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G3 - Poorly differentiated,HEAD OF PANCREAS,T2,Nx,70,61-70,7.0
CO-101-001,CO-101-001-073-008,01073008,073,63.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,54.0,>50-75,2.0,1.62,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,GASTRORRHAGIA,Y,GASTRORRHAGIA,2011-06-13,5.0,2011-06-09,,2012-10-01,Died,2.0,2.0,2.102669404517454,<=3,1.0,4.008213552361396,>3-6,2.0,-1.8726899383983573,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,Nx,10,0-10,1.0
CO-101-001,CO-101-001-073-011,01073011,073,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,91.0,>75-100,3.0,2.0,>1.75-2.0,4.0,959.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,2.0,2.4969199178644765,<=3,1.0,1.4784394250513346,<=3,1.0,1.051334702258727,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,Tx,Nx,40,31-40,4.0
CO-101-001,CO-101-001-073-012,01073012,073,53.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,156.0,>150-175,5.0,70.0,>50-75,2.0,1.74,>1.50-1.75,3.0,38600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-27,33.0,2012-03-26,2012-05-23,2012-10-01,Died,2.0,3.0,1.1498973305954825,<=3,1.0,1.1498973305954825,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,,Y,,,,Y,G1 - Well differentiated,OTHER,Tx,Nx,65,61-70,7.0
CO-101-001,CO-101-001-075-002,01075002,075,53.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,66.0,>50-75,2.0,1.82,>1.75-2.0,4.0,24400.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-06-22,119.0,2011-06-08,2011-07-08,2012-10-01,Died,2.0,4.0,2.9897330595482545,<=3,1.0,2.9897330595482545,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,Nx,15,11-20,2.0
CO-101-001,CO-101-001-075-003,01075003,075,42.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,167.0,>150-175,5.0,52.0,>50-75,2.0,1.55,>1.50-1.75,3.0,25000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROTOCOL VIOLATION,4.0,PROTOCOL VIOLATION,Y,DISEASE PROGRESSION,2011-11-11,79.0,2011-11-10,2011-12-09,2012-10-01,Died,2.0,1.0,1.0184804928131417,<=3,1.0,1.0184804928131417,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T4,N1,10,0-10,1.0
CO-101-001,CO-101-001-075-004,01075004,075,53.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,112.0,>100-125,4.0,2.34,>2.0,5.0,17700.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,ACUTE CARDIOVASCULAR FAILURE,Y,ACUTE CARDIOVASCULAR FAILURE,2012-04-04,196.0,2012-03-29,,2012-10-01,Died,2.0,2.0,1.2484599589322383,<=3,1.0,0.9527720739219713,<=3,1.0,0.32854209445585214,Y,Y,2.0,2,2.0,,,Y,,,,Y,G2 - Moderately differentiated,OTHER,T4,Nx,30,21-30,3.0
CO-101-001,CO-101-001-075-005,01075005,075,49.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,185.0,>175,6.0,76.0,>75-100,3.0,1.98,>1.75-2.0,4.0,776.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-09,129.0,2012-05-17,2012-06-18,2012-10-01,Died,2.0,3.0,0.5256673511293635,<=3,1.0,0.5256673511293635,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T2,Nx,45,41-50,5.0
CO-101-001,CO-101-001-075-007,01075007,075,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,153.0,>150-175,5.0,74.0,>50-75,2.0,1.77,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,,,,,,,,2012-10-18,,2012-10-01,,,3.0,0.9856262833675564,<=3,1.0,0.4928131416837782,<=3,1.0,0.5256673511293635,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,Unknown,TAIL OF PANCREAS,T3,Nx,2,0-10,1.0
CO-101-001,CO-101-001-076-001,01076001,076,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,185.0,>175,6.0,87.0,>75-100,3.0,2.11,>2.0,5.0,21700.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-26,34.0,2011-06-29,2011-07-29,2012-10-01,Died,2.0,2.0,1.6427104722792607,<=3,1.0,1.1498973305954825,<=3,1.0,0.5256673511293635,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N1,30,21-30,3.0
CO-101-001,CO-101-001-076-002,01076002,076,60.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,164.0,>150-175,5.0,65.0,>50-75,2.0,1.72,>1.50-1.75,3.0,31.1,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-23,116.0,2012-05-25,2012-06-25,2012-10-01,Died,2.0,2.0,2.759753593429158,<=3,1.0,1.4455852156057496,<=3,1.0,1.3470225872689938,Y,Y,1.0,1,1.0,Y,,,,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,T4,N0,10,0-10,1.0
CO-101-001,CO-101-001-078-001,01078001,078,53.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,53.2,>50-75,2.0,1.58,>1.50-1.75,3.0,4290.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-21,150.0,2011-04-20,2011-05-23,2012-10-01,Died,2.0,8.0,1.51129363449692,<=3,1.0,0.13141683778234087,<=3,1.0,1.4127310061601643,Y,Y,2.0,2,2.0,Y,,,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N1,50,41-50,5.0
CO-101-001,CO-101-001-078-003,01078003,078,70.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,155.0,>150-175,5.0,42.0,<=50,1.0,1.34,>1.25-1.50,2.0,28700.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-05-18,80.0,2011-05-14,2011-05-23,2012-10-01,Died,2.0,3.0,2.4969199178644765,<=3,1.0,2.4969199178644765,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,Nx,0,0-10,1.0
CO-101-001,CO-101-001-078-004,01078004,078,49.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,157.0,>150-175,5.0,79.0,>75-100,3.0,1.86,>1.75-2.0,4.0,8.5,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-06-02,22.0,2011-06-02,,2012-10-01,Died,2.0,2.0,13.010266940451745,>12-24,4.0,13.010266940451745,>12-24,4.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G3 - Poorly differentiated,BODY OF PANCREAS,T3,N1,70,61-70,7.0
CO-101-001,CO-101-001-078-005,01078005,078,56.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,163.0,>150-175,5.0,67.0,>50-75,2.0,1.74,>1.50-1.75,3.0,6.3,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-07,188.0,2011-10-26,2011-11-08,2012-10-01,Died,2.0,1.0,2.0698151950718686,<=3,1.0,2.0698151950718686,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,OTHER,T4,N1,10,0-10,1.0
CO-101-001,CO-101-001-078-007,01078007,078,50.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,51.0,>50-75,2.0,1.51,>1.50-1.75,3.0,3610.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-30,136.0,2011-07-20,2012-07-05,2012-10-01,Died,2.0,1.0,1.1170431211498972,<=3,1.0,1.1170431211498972,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,Y,,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-078-009,01078009,078,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,172.0,>150-175,5.0,110.0,>100-125,4.0,2.29,>2.0,5.0,1570.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-10,271.0,2012-03-23,2012-03-23,2012-10-01,Died,2.0,2.0,8.837782340862423,>6-12,3.0,8.837782340862423,>6-12,3.0,0.03285420944558522,Y,Y,3.0,3,3.0,,Y,Y,Y,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-078-011,01078011,078,71.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,RUS,RUSSIA,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,173.0,>150-175,5.0,49.0,<=50,1.0,1.53,>1.50-1.75,3.0,2740.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-10-05,311.0,2012-09-25,2012-09-25,2012-10-01,Died,2.0,3.0,3.2197125256673513,>3-6,2.0,1.379876796714579,<=3,1.0,1.8726899383983573,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-079-001,01079001,079,77.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,68.2,>50-75,2.0,1.79,>1.75-2.0,4.0,927.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-02-02,112.0,2011-01-20,,2012-10-01,Died,2.0,1.0,0.9856262833675564,<=3,1.0,0.9856262833675564,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,HEAD OF PANCREAS,T2,N0,90,81-90,9.0
CO-101-001,CO-101-001-079-002,01079002,079,70.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,45.2,<=50,1.0,1.42,>1.25-1.50,2.0,5310.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-02-04,107.0,2011-01-20,,2012-10-01,Died,2.0,1.0,1.4127310061601643,<=3,1.0,1.4127310061601643,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,,Y,,,Y,GX - Grade cannot be assessed,BODY OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-079-006,01079006,079,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,70.8,>50-75,2.0,1.8,>1.75-2.0,4.0,46000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-12,259.0,2011-07-04,2011-07-20,2012-10-01,Died,2.0,1.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,T3,N1,100,91-100,10.0
CO-101-001,CO-101-001-079-009,01079009,079,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,77.0,>75-100,3.0,1.9,>1.75-2.0,4.0,8.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-01-28,458.0,2012-01-18,2012-03-13,2012-10-01,Died,2.0,2.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,,Y,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,N1,80,71-80,8.0
CO-101-001,CO-101-001-079-010,01079010,079,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,167.0,>150-175,5.0,73.2,>50-75,2.0,1.84,>1.75-2.0,4.0,3.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2010-12-02,24.0,2010-11-23,,2012-10-01,Died,2.0,3.0,13.141683778234086,>12-24,4.0,2.4640657084188913,<=3,1.0,10.710472279260781,Y,Y,3.0,3,3.0,,,Y,Y,,,Y,GX - Grade cannot be assessed,HEAD OF PANCREAS,T3,N0,60,51-60,6.0
CO-101-001,CO-101-001-079-012,01079012,079,48.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,76.0,>75-100,3.0,1.94,>1.75-2.0,4.0,8660.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-17,234.0,2011-09-16,,2012-10-01,Died,2.0,2.0,1.0184804928131417,<=3,1.0,1.0184804928131417,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-079-013,01079013,079,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,175.0,>150-175,5.0,67.4,>50-75,2.0,1.81,>1.75-2.0,4.0,1930.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-02,346.0,2012-01-04,2012-04-10,2012-10-01,Died,2.0,1.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N0,2,0-10,1.0
CO-101-001,CO-101-001-079-014,01079014,079,58.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,57.5,>50-75,2.0,1.61,>1.50-1.75,3.0,1640.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,CAUSE UNKNOWN,2011-10-14,184.0,2011-05-25,2012-01-16,2012-10-01,Died,2.0,1.0,3.5482546201232035,>3-6,2.0,3.5482546201232035,>3-6,2.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,BODY OF PANCREAS,T4,N1,45,41-50,5.0
CO-101-001,CO-101-001-079-016,01079016,079,57.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,80.0,>75-100,3.0,2.0,>1.75-2.0,4.0,11.2,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-25,404.0,2012-06-12,2012-07-19,2012-10-01,Died,2.0,1.0,0.9856262833675564,<=3,1.0,0.9856262833675564,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,T3,N1,30,21-30,3.0
CO-101-001,CO-101-001-079-018,01079018,079,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,185.0,>175,6.0,84.0,>75-100,3.0,2.07,>2.0,5.0,922.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,,,,,,,,2012-11-01,,2012-10-01,,,1.0,9.724845995893224,>6-12,3.0,1.675564681724846,<=3,1.0,8.082135523613964,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,TAIL OF PANCREAS,T3,N0,80,71-80,8.0
CO-101-001,CO-101-001-079-019,01079019,079,65.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,76.0,>75-100,3.0,1.93,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-22,338.0,2012-06-14,,2012-10-01,Died,2.0,1.0,0.5585215605749486,<=3,1.0,0.5585215605749486,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G1 - Well differentiated,OTHER,T4,N0,20,11-20,2.0
CO-101-001,CO-101-001-079-020,01079020,079,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,55.0,>50-75,2.0,1.59,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROTOCOL VIOLATION,4.0,PROTOCOL VIOLATION,Y,CAUSE UNKNOWN,2011-10-26,16.0,2011-10-25,2012-01-17,2012-10-01,Died,2.0,2.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,Y,,,,Y,Unknown,HEAD OF PANCREAS,T3,N0,0,0-10,1.0
CO-101-001,CO-101-001-079-021,01079021,079,64.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,164.0,>150-175,5.0,80.0,>75-100,3.0,1.9,>1.75-2.0,4.0,461.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-19,79.0,2012-01-11,,2012-10-01,Died,2.0,2.0,5.453798767967146,>3-6,2.0,5.453798767967146,>3-6,2.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,HEAD OF PANCREAS,T2,N1,20,11-20,2.0
CO-101-001,CO-101-001-079-022,01079022,079,59.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,179.0,>175,6.0,92.0,>75-100,3.0,2.14,>2.0,5.0,66600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,MULTI-ORGAN FAILURE,2012-02-21,113.0,2012-02-20,,2012-10-01,Died,2.0,2.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,TAIL OF PANCREAS,T2,N1,60,51-60,6.0
CO-101-001,CO-101-001-079-023,01079023,079,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,58.0,>50-75,2.0,1.62,>1.50-1.75,3.0,3.2,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,,,,,,,,2012-10-31,,2012-10-01,,,2.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N1,40,31-40,4.0
CO-101-001,CO-101-001-079-024,01079024,079,34.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,79.0,>75-100,3.0,1.99,>1.75-2.0,4.0,73000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-06,233.0,2012-06-21,,2012-10-01,Died,2.0,2.0,11.827515400410677,>6-12,3.0,0.9527720739219713,<=3,1.0,10.907597535934292,Y,Y,2.0,2,2.0,Y,,,,,,Y,Unknown,HEAD OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-079-025,01079025,079,47.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,177.0,>175,6.0,79.0,>75-100,3.0,1.98,>1.75-2.0,4.0,93000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-04,37.0,2011-12-20,,2012-10-01,Died,2.0,2.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,Unknown,TAIL OF PANCREAS,T4,N1,30,21-30,3.0
CO-101-001,CO-101-001-079-026,01079026,079,61.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,160.0,>150-175,5.0,56.0,>50-75,2.0,1.58,>1.50-1.75,3.0,2030.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-24,12.0,2011-12-13,,2012-10-01,Died,2.0,2.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,Unknown,HEAD OF PANCREAS,T3,N1,85,81-90,9.0
CO-101-001,CO-101-001-079-027,01079027,079,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,73.0,>50-75,2.0,1.9,>1.75-2.0,4.0,422.0,>10xULN-20xULN,5.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,,,,,,,,2012-10-29,,2012-10-01,,,1.0,3.811088295687885,>3-6,2.0,0.8213552361396304,<=3,1.0,3.02258726899384,Y,Y,2.0,2,2.0,Y,,,,,,Y,G4 - Undifferentiated,HEAD OF PANCREAS,T4,N0,N/A,,
CO-101-001,CO-101-001-079-029,01079029,079,62.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,173.0,>150-175,5.0,71.0,>50-75,2.0,1.85,>1.75-2.0,4.0,17.8,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-22,163.0,2012-06-21,,2012-10-01,Died,2.0,3.0,1.4127310061601643,<=3,1.0,0.6899383983572895,<=3,1.0,0.75564681724846,Y,Y,2.0,2,2.0,Y,,,,,,Y,GX - Grade cannot be assessed,OTHER,T3,N0,1,0-10,1.0
CO-101-001,CO-101-001-079-030,01079030,079,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,152.0,>150-175,5.0,76.2,>75-100,3.0,1.79,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-10,45.0,2012-03-01,,2012-10-01,Died,2.0,1.0,0.75564681724846,<=3,1.0,0.75564681724846,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,OTHER,T4,N1,30,21-30,3.0
CO-101-001,CO-101-001-080-001,01080001,080,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,164.0,>150-175,5.0,61.0,>50-75,2.0,1.67,>1.50-1.75,3.0,304.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-16,584.0,2012-05-02,2012-06-04,2012-10-01,Died,2.0,5.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,OTHER,Tx,N0,0,0-10,1.0
CO-101-001,CO-101-001-080-005,01080005,080,48.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,150.0,>125-150,4.0,54.0,>50-75,2.0,1.5,>1.25-1.50,2.0,25.6,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-07-07,253.0,2011-06-16,2011-07-14,2012-10-01,Died,2.0,2.0,1.379876796714579,<=3,1.0,1.379876796714579,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,,Y,,Y,,Y,,Unknown,BODY OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-080-009,01080009,080,54.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,182.0,>175,6.0,96.0,>75-100,3.0,2.2,>2.0,5.0,2260.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-25,365.0,2012-01-05,2012-01-27,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.459958932238193,<=3,1.0,0.5585215605749486,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N1,0,0-10,1.0
CO-101-001,CO-101-001-080-011,01080011,080,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,54.0,>50-75,2.0,1.56,>1.50-1.75,3.0,25.3,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-09-25,595.0,2012-09-17,2012-10-23,2012-10-01,Died,2.0,2.0,7.129363449691992,>6-12,3.0,0.9527720739219713,<=3,1.0,6.209445585215605,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,Nx,70,61-70,7.0
CO-101-001,CO-101-001-080-013,01080013,080,48.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,60.0,>50-75,2.0,1.7,>1.50-1.75,3.0,126.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-24,209.0,2011-09-19,,2012-10-01,Died,2.0,4.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,,Y,G3 - Poorly differentiated,HEAD OF PANCREAS,T4,N0,20,11-20,2.0
CO-101-001,CO-101-001-080-014,01080014,080,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,56.0,>50-75,2.0,1.57,>1.50-1.75,3.0,5.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-09,257.0,2011-12-15,2012-01-16,2012-10-01,Died,2.0,2.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,Y,,,,G3 - Poorly differentiated,OTHER,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-080-015,01080015,080,60.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,163.0,>150-175,5.0,74.0,>50-75,2.0,1.83,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,2.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N1,5,0-10,1.0
CO-101-001,CO-101-001-080-016,01080016,080,54.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,67.0,>50-75,2.0,1.81,>1.75-2.0,4.0,48700.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-22,89.0,2011-07-14,2011-08-29,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.9856262833675564,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,Y,Y,,,,Y,G2 - Moderately differentiated,OTHER,T4,N1,50,41-50,5.0
CO-101-001,CO-101-001-080-019,01080019,080,82.0,YEARS,81-90,5.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,149.0,>125-150,4.0,49.1,<=50,1.0,1.42,>1.25-1.50,2.0,28600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-25,116.0,2011-09-15,2011-10-13,2012-10-01,Died,2.0,2.0,0.459958932238193,<=3,1.0,0.459958932238193,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,,,,,,Y,G2 - Moderately differentiated,TAIL OF PANCREAS,T4,N0,70,61-70,7.0
CO-101-001,CO-101-001-080-020,01080020,080,58.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,63.0,>50-75,2.0,1.68,>1.50-1.75,3.0,2830.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-02,107.0,2011-10-31,2011-11-30,2012-10-01,Died,2.0,2.0,1.3470225872689938,<=3,1.0,1.3470225872689938,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,HEAD OF PANCREAS,T1,N1,0,0-10,1.0
CO-101-001,CO-101-001-080-022,01080022,080,54.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,175.0,>150-175,5.0,84.0,>75-100,3.0,2.02,>2.0,5.0,106000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-08,119.0,2011-12-20,2012-01-10,2012-10-01,Died,2.0,4.0,1.2484599589322383,<=3,1.0,0.9527720739219713,<=3,1.0,0.32854209445585214,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N0,50,41-50,5.0
CO-101-001,CO-101-001-080-023,01080023,080,72.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,155.0,>150-175,5.0,56.0,>50-75,2.0,1.55,>1.50-1.75,3.0,3350.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-27,290.0,2012-06-07,2012-07-06,2012-10-01,Died,2.0,4.0,9.100616016427105,>6-12,3.0,1.7741273100616017,<=3,1.0,7.359342915811088,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,OTHER,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-080-024,01080024,080,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,53.0,>50-75,2.0,1.56,>1.50-1.75,3.0,3920.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-07,236.0,2012-05-04,2012-05-04,2012-10-01,Died,2.0,2.0,1.7084188911704312,<=3,1.0,1.7084188911704312,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N0,5,0-10,1.0
CO-101-001,CO-101-001-080-025,01080025,080,68.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,87.0,>75-100,3.0,2.0,>1.75-2.0,4.0,9490.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,THROMBEMBOLIA OF LEFT PULMONARY ARTERY,2011-12-19,96.0,2011-12-15,2011-12-19,2012-10-01,Died,2.0,2.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,OTHER,T3,Nx,20,11-20,2.0
CO-101-001,CO-101-001-080-026,01080026,080,52.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,161.0,>150-175,5.0,69.1,>50-75,2.0,1.76,>1.75-2.0,4.0,71100.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-15,58.0,2011-10-10,2011-11-17,2012-10-01,Died,2.0,4.0,7.7207392197125255,>6-12,3.0,0.75564681724846,<=3,1.0,6.997946611909651,Y,Y,2.0,2,2.0,Y,,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T2,Nx,20,11-20,2.0
CO-101-001,CO-101-001-080-027,01080027,080,45.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,181.0,>175,6.0,67.0,>50-75,2.0,1.84,>1.75-2.0,4.0,134.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-07,253.0,2012-05-16,2012-06-07,2012-10-01,Died,2.0,2.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N1,90,81-90,9.0
CO-101-001,CO-101-001-080-028,01080028,080,45.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,68.5,>50-75,2.0,1.85,>1.75-2.0,4.0,7730.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-30,177.0,2012-03-16,2012-04-17,2012-10-01,Died,2.0,2.0,0.4928131416837782,<=3,1.0,0.4928131416837782,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,OTHER,T3,N0,1,0-10,1.0
CO-101-001,CO-101-001-080-030,01080030,080,36.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,164.0,>150-175,5.0,76.0,>75-100,3.0,1.86,>1.75-2.0,4.0,72800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-17,97.0,2011-12-21,,2012-10-01,Died,2.0,2.0,1.215605749486653,<=3,1.0,1.215605749486653,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G3 - Poorly differentiated,OTHER,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-080-031,01080031,080,48.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,167.0,>150-175,5.0,61.0,>50-75,2.0,1.68,>1.50-1.75,3.0,494.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-07,143.0,2012-04-05,2012-05-07,2012-10-01,Died,2.0,1.0,1.0184804928131417,<=3,1.0,1.0184804928131417,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,5,0-10,1.0
CO-101-001,CO-101-001-080-032,01080032,080,58.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,169.0,>150-175,5.0,65.1,>50-75,2.0,1.75,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-01-17,57.0,2011-12-27,2012-02-09,2012-10-01,Died,2.0,2.0,0.8213552361396304,<=3,1.0,0.8213552361396304,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N1,30,21-30,3.0
CO-101-001,CO-101-001-080-033,01080033,080,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,92.1,>75-100,3.0,2.14,>2.0,5.0,1500.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-21,265.0,2012-08-16,2012-08-21,2012-10-01,Died,2.0,2.0,10.841889117043122,>6-12,3.0,10.841889117043122,>6-12,3.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N0,20,11-20,2.0
CO-101-001,CO-101-001-080-034,01080034,080,52.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,40.0,<=50,1.0,1.32,>1.25-1.50,2.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-01-10,6.0,2012-01-05,,2012-10-01,Died,2.0,1.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,Y,Y,Y,,,Y,G3 - Poorly differentiated,OTHER,T2,N1,5,0-10,1.0
CO-101-001,CO-101-001-080-035,01080035,080,53.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,74.1,>50-75,2.0,1.86,>1.75-2.0,4.0,45.9,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-03-17,80.0,2012-03-02,2012-04-02,2012-10-01,Died,2.0,1.0,0.4928131416837782,<=3,1.0,0.4928131416837782,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N1,100,91-100,10.0
CO-101-001,CO-101-001-080-036,01080036,080,65.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,90.1,>75-100,3.0,2.01,>2.0,5.0,16.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-06,136.0,2012-05-21,2012-06-08,2012-10-01,Died,2.0,1.0,4.731006160164271,>3-6,2.0,-7.293634496919918,,,12.057494866529774,Y,Y,4.0,4,4.0,Y,Y,Y,,,,Y,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N0,0,0-10,1.0
CO-101-001,CO-101-001-080-037,01080037,080,60.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,155.0,>150-175,5.0,61.1,>50-75,2.0,1.62,>1.50-1.75,3.0,470.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-30,184.0,2012-08-20,2012-09-20,2012-10-01,Died,2.0,1.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,,Y,Y,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N0,30,21-30,3.0
CO-101-001,CO-101-001-080-038,01080038,080,52.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,58.0,>50-75,2.0,1.68,>1.50-1.75,3.0,107.0,>2xULN-3xULN,3.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-08-06,148.0,2012-08-02,2012-08-28,2012-10-01,Died,2.0,6.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G2 - Moderately differentiated,OTHER,T3,Nx,10,0-10,1.0
CO-101-001,CO-101-001-080-039,01080039,080,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,65.2,>50-75,2.0,1.73,>1.50-1.75,3.0,1040.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-26,114.0,2012-07-02,2012-09-03,2012-10-01,Died,2.0,2.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,,Y,Unknown,HEAD OF PANCREAS,T2,N0,15,11-20,2.0
CO-101-001,CO-101-001-080-040,01080040,080,51.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,76.0,>75-100,3.0,1.92,>1.75-2.0,4.0,11.6,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-10-14,193.0,2012-09-28,2012-10-23,2012-10-01,Died,2.0,3.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,OTHER,T2,N0,75,71-80,8.0
CO-101-001,CO-101-001-081-001,01081001,081,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,175.0,>150-175,5.0,64.0,>50-75,2.0,1.78,>1.75-2.0,4.0,17.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-04,177.0,2011-04-26,2011-05-20,2012-10-01,Died,2.0,1.0,1.675564681724846,<=3,1.0,1.6098562628336757,<=3,1.0,0.09856262833675565,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,N0,0,0-10,1.0
CO-101-001,CO-101-001-081-004,01081004,081,68.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,158.0,>150-175,5.0,67.0,>50-75,2.0,1.71,>1.50-1.75,3.0,310.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-29,352.0,2011-11-28,2011-12-28,2012-10-01,Died,2.0,4.0,1.4784394250513346,<=3,1.0,1.4784394250513346,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,T3,N1,70,61-70,7.0
CO-101-001,CO-101-001-081-005,01081005,081,67.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,156.0,>150-175,5.0,60.0,>50-75,2.0,1.59,>1.50-1.75,3.0,63.2,>ULN-2xULN,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-12-27,323.0,2011-12-09,2011-12-09,2012-10-01,Died,2.0,2.0,3.2197125256673513,>3-6,2.0,3.0882956878850103,>3-6,2.0,0.16427104722792607,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T3,N1,40,31-40,4.0
CO-101-001,CO-101-001-081-006,01081006,081,50.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,64.0,>50-75,2.0,1.77,>1.75-2.0,4.0,18800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-04-13,42.0,2011-04-04,,2012-10-01,Died,2.0,1.0,1.379876796714579,<=3,1.0,1.2484599589322383,<=3,1.0,0.16427104722792607,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T3,Nx,10,0-10,1.0
CO-101-001,CO-101-001-081-010,01081010,081,46.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,155.0,>150-175,5.0,48.0,<=50,1.0,1.44,>1.25-1.50,2.0,965000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-19,111.0,2011-11-15,,2012-10-01,Died,2.0,1.0,1.839835728952772,<=3,1.0,1.3470225872689938,<=3,1.0,0.5256673511293635,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T3,Nx,20,11-20,2.0
CO-101-001,CO-101-001-081-011,01081011,081,65.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,176.0,>175,6.0,84.0,>75-100,3.0,2.01,>2.0,5.0,15000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-18,83.0,2012-01-23,,2012-10-01,Died,2.0,4.0,1.051334702258727,<=3,1.0,0.5913757700205339,<=3,1.0,0.4928131416837782,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T3,N1,60,51-60,6.0
CO-101-001,CO-101-001-081-012,01081012,081,39.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,49.0,<=50,1.0,1.52,>1.50-1.75,3.0,7520.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-22,2012-10-22,2012-10-01,Alive,1.0,1.0,1.3470225872689938,<=3,1.0,1.1498973305954825,<=3,1.0,0.2299794661190965,Y,Y,2.0,2,2.0,Y,Y,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N1,40,31-40,4.0
CO-101-001,CO-101-001-082-001,01082001,082,54.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,75.0,>50-75,2.0,1.77,>1.75-2.0,4.0,748.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-15,195.0,2011-02-08,2011-11-11,2012-10-01,Died,2.0,4.0,4.402464065708419,>3-6,2.0,3.055441478439425,>3-6,2.0,1.379876796714579,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,T4,Nx,5,0-10,1.0
CO-101-001,CO-101-001-082-002,01082002,082,65.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,172.0,>150-175,5.0,73.0,>50-75,2.0,1.86,>1.75-2.0,4.0,116000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-03-16,38.0,2011-03-09,,2012-10-01,Died,2.0,4.0,2.135523613963039,<=3,1.0,2.004106776180698,<=3,1.0,0.16427104722792607,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-082-004,01082004,082,69.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,167.0,>150-175,5.0,89.0,>75-100,3.0,2.03,>2.0,5.0,163.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,,,,,2012-04-26,2012-04-26,2012-10-01,Lost to Follow-up,3.0,4.0,3.2854209445585214,>3-6,2.0,2.924024640657084,<=3,1.0,0.3942505133470226,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-083-001,01083001,083,72.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,163.0,>150-175,5.0,86.0,>75-100,3.0,1.97,>1.75-2.0,4.0,569000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-06-13,97.0,2011-06-02,2011-06-02,2012-10-01,Died,2.0,1.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,OTHER,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-083-002,01083002,083,62.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,169.0,>150-175,5.0,71.0,>50-75,2.0,1.83,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-06-13,62.0,2011-05-25,2011-07-04,2012-10-01,Died,2.0,1.0,0.6570841889117043,<=3,1.0,0.9527720739219713,<=3,1.0,-0.26283367556468173,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G4 - Undifferentiated,OTHER,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-083-005,01083005,083,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,166.0,>150-175,5.0,47.0,<=50,1.0,1.47,>1.25-1.50,2.0,16600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-03,207.0,2012-02-21,2012-03-20,2012-10-01,Died,2.0,1.0,0.8870636550308009,<=3,1.0,1.1170431211498972,<=3,1.0,-0.1971252566735113,Y,Y,5.0,>=5,5.0,Y,Y,,Y,,,Y,Unknown,OTHER,T4,N1,15,11-20,2.0
CO-101-001,CO-101-001-083-006,01083006,083,63.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,179.0,>175,6.0,70.0,>50-75,2.0,1.87,>1.75-2.0,4.0,10200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-24,66.0,2011-11-15,2011-12-13,2012-10-01,Died,2.0,1.0,1.4127310061601643,<=3,1.0,2.4640657084188913,<=3,1.0,-1.0184804928131417,Y,Y,5.0,>=5,5.0,Y,Y,,Y,,,Y,G3 - Poorly differentiated,OTHER,T4,N1,50,41-50,5.0
CO-101-001,CO-101-001-083-008,01083008,083,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,172.0,>150-175,5.0,72.0,>50-75,2.0,1.86,>1.75-2.0,4.0,15.7,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-05,136.0,2012-03-27,2012-04-24,2012-10-01,Died,2.0,2.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,Y,,Y,,,Y,GX - Grade cannot be assessed,BODY OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-083-010,01083010,083,53.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,163.0,>150-175,5.0,67.0,>50-75,2.0,1.74,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-05,84.0,2012-02-14,2012-03-13,2012-10-01,Died,2.0,16.0,0.8542094455852156,<=3,1.0,0.8542094455852156,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,,Y,Y,,,,Y,GX - Grade cannot be assessed,OTHER,T4,N1,40,31-40,4.0
CO-101-001,CO-101-001-083-011,01083011,083,67.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,170.0,>150-175,5.0,69.0,>50-75,2.0,1.81,>1.75-2.0,4.0,41900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-04,68.0,2012-01-24,2012-02-23,2012-10-01,Died,2.0,2.0,0.6242299794661191,<=3,1.0,0.6899383983572895,<=3,1.0,-0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,OTHER,T3,N1,5,0-10,1.0
CO-101-001,CO-101-001-083-013,01083013,083,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,178.0,>175,6.0,74.0,>50-75,2.0,1.9,>1.75-2.0,4.0,34.2,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,2.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,T3,N1,60,51-60,6.0
CO-101-001,CO-101-001-083-015,01083015,083,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,169.0,>150-175,5.0,75.0,>50-75,2.0,1.88,>1.75-2.0,4.0,18400.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-21,27.0,2012-02-08,2012-02-29,2012-10-01,Died,2.0,2.0,1.7084188911704312,<=3,1.0,1.7084188911704312,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,Y,,,,,G2 - Moderately differentiated,OTHER,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-083-017,01083017,083,40.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,159.0,>150-175,5.0,73.0,>50-75,2.0,1.8,>1.75-2.0,4.0,29700.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-24,2012-10-24,2012-10-01,Alive,1.0,2.0,0.9527720739219713,<=3,1.0,0.4928131416837782,<=3,1.0,0.4928131416837782,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,OTHER,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-083-018,01083018,083,58.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,54.0,>50-75,2.0,1.6,>1.50-1.75,3.0,8.3,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE PROGRESSION,2012-08-01,156.0,2012-07-10,2012-08-07,2012-10-01,Died,2.0,2.0,0.919917864476386,<=3,1.0,0.459958932238193,<=3,1.0,0.4928131416837782,Y,Y,2.0,2,2.0,Y,,,,,,Y,G3 - Poorly differentiated,BODY OF PANCREAS,T3,Nx,85,81-90,9.0
CO-101-001,CO-101-001-084-001,01084001,084,45.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,180.0,>175,6.0,63.4,>50-75,2.0,1.78,>1.75-2.0,4.0,1070.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-11,432.0,2012-05-27,2012-05-27,2012-10-01,Died,2.0,2.0,1.675564681724846,<=3,1.0,0.9527720739219713,<=3,1.0,0.75564681724846,Y,Y,2.0,2,2.0,Y,,Y,,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,T2,Nx,40,31-40,4.0
CO-101-001,CO-101-001-084-002,01084002,084,51.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,183.0,>175,6.0,102.0,>100-125,4.0,2.27,>2.0,5.0,39000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-14,89.0,2011-07-20,2011-08-20,2012-10-01,Died,2.0,1.0,1.2484599589322383,<=3,1.0,1.2484599589322383,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,GX - Grade cannot be assessed,TAIL OF PANCREAS,T3,Nx,30,21-30,3.0
CO-101-001,CO-101-001-084-004,01084004,084,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,162.0,>150-175,5.0,49.4,<=50,1.0,1.49,>1.25-1.50,2.0,798000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,PROGRESSION OF METASTATIC PANCREATIC ADENOCARCINOMA,Y,PROGRESSION OF METASTATIC PANCREATIC ADENOCARCINOMA,2011-09-04,54.0,2011-08-31,,2012-10-01,Died,2.0,2.0,1.3141683778234086,<=3,1.0,0.8870636550308009,<=3,1.0,0.459958932238193,Y,Y,4.0,4,4.0,Y,Y,Y,,,,Y,GX - Grade cannot be assessed,OTHER,T2,Nx,0,0-10,1.0
CO-101-001,CO-101-001-084-005,01084005,084,44.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,166.0,>150-175,5.0,68.3,>50-75,2.0,1.77,>1.75-2.0,4.0,34300.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-22,170.0,2012-03-02,2012-04-02,2012-10-01,Died,2.0,2.0,0.8870636550308009,<=3,1.0,0.8870636550308009,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,OTHER,T3,Nx,60,51-60,6.0
CO-101-001,CO-101-001-084-007,01084007,084,75.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,152.0,>150-175,5.0,57.2,>50-75,2.0,1.55,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,2012-10-23,2012-10-01,Alive,1.0,3.0,1.6098562628336757,<=3,1.0,1.6098562628336757,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,,Y,,,,Y,GX - Grade cannot be assessed,TAIL OF PANCREAS,T4,Nx,40,31-40,4.0
CO-101-001,CO-101-001-084-008,01084008,084,73.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,168.0,>150-175,5.0,60.4,>50-75,2.0,1.68,>1.50-1.75,3.0,87.9,>2xULN-3xULN,3.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-24,126.0,2012-03-23,2012-03-23,2012-10-01,Died,2.0,3.0,2.924024640657084,<=3,1.0,2.924024640657084,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,T3,Nx,2,0-10,1.0
CO-101-001,CO-101-001-084-010,01084010,084,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,164.0,>150-175,5.0,58.3,>50-75,2.0,1.63,>1.50-1.75,3.0,9.4,<=ULN,1.0,Y,Y,N,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,N/A,3.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-06-14,170.0,2012-06-10,2012-07-10,2012-10-01,Died,2.0,3.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,Y,,,,,G3 - Poorly differentiated,OTHER,T4,Nx,N/A,,
CO-101-001,CO-101-001-084-011,01084011,084,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,68.3,>50-75,2.0,1.82,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,,,,,,,,2012-10-17,,2012-10-01,,,3.0,1.7741273100616017,<=3,1.0,1.3141683778234086,<=3,1.0,0.4928131416837782,Y,Y,1.0,1,1.0,,,Y,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-084-012,01084012,084,62.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,172.0,>150-175,5.0,63.4,>50-75,2.0,1.74,>1.50-1.75,3.0,24800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,,,,,2012-04-20,2012-04-20,2012-10-01,Lost to Follow-up,3.0,3.0,7.5564681724846,>6-12,3.0,5.9137577002053385,>3-6,2.0,1.675564681724846,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,BODY OF PANCREAS,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-085-001,01085001,085,50.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,174.0,>150-175,5.0,69.0,>50-75,2.0,1.83,>1.75-2.0,4.0,95400.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-08-15,120.0,2011-08-03,,2012-10-01,Died,2.0,5.0,2.858316221765914,<=3,1.0,2.858316221765914,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,GX - Grade cannot be assessed,TAIL OF PANCREAS,T3,N0,60,51-60,6.0
CO-101-001,CO-101-001-085-002,01085002,085,52.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,177.0,>175,6.0,76.0,>75-100,3.0,1.93,>1.75-2.0,4.0,,,,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-03,451.0,2012-07-25,2012-08-05,2012-10-01,Died,2.0,2.0,1.5441478439425051,<=3,1.0,1.5441478439425051,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,Unknown,TAIL OF PANCREAS,T3,N0,30,21-30,3.0
CO-101-001,CO-101-001-086-003,01086003,086,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,168.0,>150-175,5.0,81.0,>75-100,3.0,1.8,>1.75-2.0,4.0,4970.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-02-25,93.0,2011-02-11,2011-02-11,2012-10-01,Died,2.0,1.0,0.5585215605749486,<=3,1.0,0.5585215605749486,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T4,N1,15,11-20,2.0
CO-101-001,CO-101-001-086-004,01086004,086,50.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,188.0,>175,6.0,127.0,>125-150,5.0,2.4,>2.0,5.0,442.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-03-27,11.0,2011-03-24,,2012-10-01,Died,2.0,1.0,0.7885010266940452,<=3,1.0,0.7885010266940452,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,Y,,,,,G4 - Undifferentiated,BODY OF PANCREAS,T4,N0,30,21-30,3.0
CO-101-001,CO-101-001-086-005,01086005,086,58.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,174.0,>150-175,5.0,69.0,>50-75,2.0,1.83,>1.75-2.0,4.0,60.6,>ULN-2xULN,2.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-06,178.0,2011-10-01,2011-10-10,2012-10-01,Died,2.0,2.0,1.2813141683778233,<=3,1.0,1.2813141683778233,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,BODY OF PANCREAS,T4,N1,30,21-30,3.0
CO-101-001,CO-101-001-086-006,01086006,086,63.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,180.0,>175,6.0,63.0,>50-75,2.0,1.77,>1.75-2.0,4.0,105000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-05-31,43.0,2011-05-31,,2012-10-01,Died,2.0,1.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,50,41-50,5.0
CO-101-001,CO-101-001-086-007,01086007,086,74.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,1.0,2.0,1.0,1,2.0,165.0,>150-175,5.0,51.0,>50-75,2.0,1.55,>1.50-1.75,3.0,2250.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-06,190.0,2011-12-02,2011-12-29,2012-10-01,Died,2.0,1.0,1.5441478439425051,<=3,1.0,1.5441478439425051,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,,,,,,Y,Unknown,HEAD OF PANCREAS,T4,N0,60,51-60,6.0
CO-101-001,CO-101-001-086-008,01086008,086,49.0,YEARS,<=50,1.0,<65,1.0,M,WHITE,5.0,UKR,UKRAINE,Eastern Europe,3.0,Eastern Europe,3.0,Eastern Europe,2.0,0.0,2.0,0.0,0,1.0,173.0,>150-175,5.0,50.0,<=50,1.0,1.55,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-10,152.0,2011-11-30,2011-12-29,2012-10-01,Died,2.0,1.0,1.1827515400410678,<=3,1.0,0.9527720739219713,<=3,1.0,0.26283367556468173,Y,Y,1.0,1,1.0,Y,,,,,,,GX - Grade cannot be assessed,BODY OF PANCREAS,T4,N1,60,51-60,6.0
CO-101-001,CO-101-001-088-002,01088002,088,70.0,YEARS,61-70,3.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,156.0,>150-175,5.0,57.5,>50-75,2.0,1.56,>1.50-1.75,3.0,2970.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-02-09,246.0,2012-01-20,2012-01-20,2012-10-01,Died,2.0,2.0,5.223819301848049,>3-6,2.0,1.3470225872689938,<=3,1.0,3.909650924024641,Y,Y,3.0,3,3.0,Y,,Y,Y,,,,G2 - Moderately differentiated,BODY OF PANCREAS,T1,N0,5,0-10,1.0
CO-101-001,CO-101-001-088-003,01088003,088,71.0,YEARS,71-80,4.0,>=65,2.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.0,>150-175,5.0,64.0,>50-75,2.0,1.74,>1.50-1.75,3.0,53000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-16,170.0,2011-11-14,2011-11-14,2012-10-01,Died,2.0,2.0,1.9712525667351128,<=3,1.0,1.2813141683778233,<=3,1.0,0.7227926078028748,Y,Y,4.0,4,4.0,Y,Y,Y,Y,,,,Unknown,OTHER,Tx,Nx,60,51-60,6.0
CO-101-001,CO-101-001-088-004,01088004,088,68.0,YEARS,61-70,3.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,158.0,>150-175,5.0,52.0,>50-75,2.0,1.51,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,SEPSIS GRADE 5,2011-07-05,26.0,2011-06-30,,2012-10-01,Died,2.0,2.0,1.2484599589322383,<=3,1.0,1.1498973305954825,<=3,1.0,0.13141683778234087,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T4,Unknown,5,0-10,1.0
CO-101-001,CO-101-001-088-005,01088005,088,82.0,YEARS,81-90,5.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,169.0,>150-175,5.0,65.0,>50-75,2.0,1.79,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-12,246.0,2012-02-27,2012-03-12,2012-10-01,Died,2.0,1.0,1.379876796714579,<=3,1.0,0.6570841889117043,<=3,1.0,0.75564681724846,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,Tx,Nx,45,41-50,5.0
CO-101-001,CO-101-001-088-006,01088006,088,65.0,YEARS,61-70,3.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.0,>150-175,5.0,59.0,>50-75,2.0,1.61,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-04,389.0,2012-07-09,2012-08-04,2012-10-01,Died,2.0,2.0,0.9527720739219713,<=3,1.0,0.5256673511293635,<=3,1.0,0.459958932238193,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,OTHER,Tx,Nx,30,21-30,3.0
CO-101-001,CO-101-001-088-007,01088007,088,71.0,YEARS,71-80,4.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,153.0,>150-175,5.0,52.0,>50-75,2.0,1.46,>1.25-1.50,2.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-10,2012-10-10,2012-10-01,Alive,1.0,2.0,0.7227926078028748,<=3,1.0,0.4271047227926078,<=3,1.0,0.32854209445585214,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,Tx,Nx,10,0-10,1.0
CO-101-001,CO-101-001-088-008,01088008,088,67.0,YEARS,61-70,3.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,157.0,>150-175,5.0,50.0,<=50,1.0,1.48,>1.25-1.50,2.0,177000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-02,78.0,2011-11-23,2011-11-23,2012-10-01,Died,2.0,2.0,1.839835728952772,<=3,1.0,0.4928131416837782,<=3,1.0,1.379876796714579,Y,Y,2.0,2,2.0,Y,,Y,,,,,G3 - Poorly differentiated,OTHER,T4,Nx,0,0-10,1.0
CO-101-001,CO-101-001-088-009,01088009,088,57.0,YEARS,51-60,2.0,<65,1.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,168.0,>150-175,5.0,94.0,>75-100,3.0,2.05,>2.0,5.0,10800.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-11,2012-10-11,2012-10-01,Alive,1.0,2.0,1.1170431211498972,<=3,1.0,0.919917864476386,<=3,1.0,0.2299794661190965,Y,Y,2.0,2,2.0,Y,,,,,,Y,Unknown,OTHER,Tx,Nx,20,11-20,2.0
CO-101-001,CO-101-001-088-010,01088010,088,64.0,YEARS,61-70,3.0,<65,1.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,170.0,>150-175,5.0,67.0,>50-75,2.0,1.77,>1.75-2.0,4.0,559.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-17,2012-10-17,2012-10-01,Alive,1.0,3.0,13.995893223819301,>12-24,4.0,0.8542094455852156,<=3,1.0,13.174537987679672,Y,Y,2.0,2,2.0,Y,Y,,,,,,G1 - Well differentiated,HEAD OF PANCREAS,T3,N0,15,11-20,2.0
CO-101-001,CO-101-001-088-011,01088011,088,69.0,YEARS,61-70,3.0,>=65,2.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,159.0,>150-175,5.0,50.0,<=50,1.0,1.51,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-10-02,260.0,2012-09-04,2012-10-02,2012-10-01,Died,2.0,7.0,5.782340862422998,>3-6,2.0,1.4455852156057496,<=3,1.0,4.369609856262834,Y,Y,3.0,3,3.0,Y,,Y,Y,,,,Unknown,HEAD OF PANCREAS,T3,N1,40,31-40,4.0
CO-101-001,CO-101-001-089-001,01089001,089,69.0,YEARS,61-70,3.0,>=65,2.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,170.0,>150-175,5.0,68.0,>50-75,2.0,1.79,>1.75-2.0,4.0,7600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-11-27,313.0,2011-11-16,2011-11-16,2012-10-01,Died,2.0,1.0,1.215605749486653,<=3,1.0,1.215605749486653,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,OTHER,T3,N1,40,31-40,4.0
CO-101-001,CO-101-001-089-002,01089002,089,61.0,YEARS,61-70,3.0,<65,1.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,160.0,>150-175,5.0,55.0,>50-75,2.0,1.56,>1.50-1.75,3.0,20.6,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-26,158.0,2011-11-16,2011-11-16,2012-10-01,Died,2.0,2.0,0.919917864476386,<=3,1.0,0.3942505133470226,<=3,1.0,0.5585215605749486,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T3,N1,0,0-10,1.0
CO-101-001,CO-101-001-089-003,01089003,089,45.0,YEARS,<=50,1.0,<65,1.0,F,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,164.0,>150-175,5.0,62.0,>50-75,2.0,1.67,>1.50-1.75,3.0,47200.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-10-02,462.0,2012-09-17,2012-10-02,2012-10-01,Died,2.0,1.0,1.1827515400410678,<=3,1.0,1.1498973305954825,<=3,1.0,0.06570841889117043,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T3,N0,60,51-60,6.0
CO-101-001,CO-101-001-089-004,01089004,089,74.0,YEARS,71-80,4.0,>=65,2.0,M,,,FRA,FRANCE,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,172.0,>150-175,5.0,78.5,>75-100,3.0,1.93,>1.75-2.0,4.0,629.0,>10xULN-20xULN,5.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,AUTOLYSIS,2012-04-19,93.0,2012-04-03,,2012-10-01,Died,2.0,1.0,0.9527720739219713,<=3,1.0,0.75564681724846,<=3,1.0,0.2299794661190965,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,TAIL OF PANCREAS,Unknown,N0,0,0-10,1.0
CO-101-001,CO-101-001-090-001,01090001,090,62.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,176.0,>175,6.0,72.5,>50-75,2.0,1.8,>1.75-2.0,4.0,145000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,GASTROINTESTINAL BLEEDING DUE TO PANCREAS CANCER,2012-01-10,392.0,2011-12-27,2011-12-27,2012-10-01,Died,2.0,3.0,2.102669404517454,<=3,1.0,2.102669404517454,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T2,N0,30,21-30,3.0
CO-101-001,CO-101-001-090-002,01090002,090,63.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,172.0,>150-175,5.0,74.9,>50-75,2.0,1.87,>1.75-2.0,4.0,6810.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-28,409.0,2012-04-10,2012-05-07,2012-10-01,Died,2.0,3.0,0.75564681724846,<=3,1.0,0.75564681724846,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N0,5,0-10,1.0
CO-101-001,CO-101-001-090-003,01090003,090,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,183.0,>175,6.0,85.5,>75-100,3.0,2.1,>2.0,5.0,2060000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-09-26,169.0,2011-09-15,2011-09-15,2012-10-01,Died,2.0,4.0,1.051334702258727,<=3,1.0,0.8213552361396304,<=3,1.0,0.26283367556468173,Y,Y,4.0,4,4.0,Y,Y,,,,,Y,Unknown,HEAD OF PANCREAS,T4,N1,0,0-10,1.0
CO-101-001,CO-101-001-090-004,01090004,090,68.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,181.0,>175,6.0,102.0,>100-125,4.0,2.23,>2.0,5.0,49.4,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,DEATH,2.0,SUDDEN HEART DEATH,Y,SUDDEN HEART DEATH,2012-05-21,357.0,2012-05-16,,2012-10-01,Died,2.0,2.0,1.51129363449692,<=3,1.0,1.51129363449692,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,T2,N1,0,0-10,1.0
CO-101-001,CO-101-001-090-005,01090005,090,76.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,SWE,SWEDEN,Western Europe,2.0,Western Europe,2.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,152.0,>150-175,5.0,51.7,>50-75,2.0,1.45,>1.25-1.50,2.0,27500.0,>50xULN,7.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-20,142.0,2011-10-04,2011-10-04,2012-10-01,Died,2.0,3.0,1.0841889117043122,<=3,1.0,1.0841889117043122,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,T2,N0,N/A,,
CO-101-001,CO-101-001-092-002,01092002,092,66.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,171.5,>150-175,5.0,72.6,>50-75,2.0,1.84,>1.75-2.0,4.0,10.0,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,,,,,,,,2012-10-30,,2012-10-01,,,4.0,2.004106776180698,<=3,1.0,2.004106776180698,<=3,1.0,0.03285420944558522,Y,Y,5.0,>=5,5.0,Y,,Y,Y,,Y,Y,Unknown,TAIL OF PANCREAS,T3,Unknown,20,11-20,2.0
CO-101-001,CO-101-001-092-003,01092003,092,76.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,177.8,>175,6.0,96.6,>75-100,3.0,2.14,>2.0,5.0,1920.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-20,287.0,2012-05-04,2012-05-04,2012-10-01,Died,2.0,4.0,0.6242299794661191,<=3,1.0,0.6242299794661191,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,80,71-80,8.0
CO-101-001,CO-101-001-092-007,01092007,092,80.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,170.2,>150-175,5.0,103.0,>100-125,4.0,2.13,>2.0,5.0,9810.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,METASTATIC PANCREATIC CARINOMA,2012-04-21,72.0,2012-04-10,2012-04-23,2012-10-01,Died,2.0,3.0,0.6899383983572895,<=3,1.0,0.6899383983572895,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,,Y,,Y,,G2 - Moderately differentiated,BODY OF PANCREAS,Unknown,Unknown,20,11-20,2.0
CO-101-001,CO-101-001-092-008,01092008,092,74.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.1,>150-175,5.0,65.4,>50-75,2.0,1.7,>1.50-1.75,3.0,55900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-08-26,189.0,2012-08-02,2012-08-02,2012-10-01,Died,2.0,4.0,0.7227926078028748,<=3,1.0,0.7227926078028748,<=3,1.0,0.03285420944558522,Y,Y,7.0,>=5,5.0,Y,Y,Y,Y,,,Y,G1 - Well differentiated,TAIL OF PANCREAS,Unknown,Unknown,30,21-30,3.0
CO-101-001,CO-101-001-092-010,01092010,092,57.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,171.5,>150-175,5.0,88.9,>75-100,3.0,2.02,>2.0,5.0,51.3,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-19,153.0,2012-08-07,2012-08-07,2012-10-01,Died,2.0,2.0,1.215605749486653,<=3,1.0,0.919917864476386,<=3,1.0,0.32854209445585214,Y,Y,2.0,2,2.0,Y,Y,,,,,,G3 - Poorly differentiated,BODY OF PANCREAS,T4,N1,60,51-60,6.0
CO-101-001,CO-101-001-093-001,01093001,093,74.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,183.1,>175,6.0,90.1,>75-100,3.0,2.13,>2.0,5.0,64400.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2011-11-21,148.0,2011-11-18,2011-11-18,2012-10-01,Died,2.0,4.0,0.4928131416837782,<=3,1.0,0.4928131416837782,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,BODY OF PANCREAS,Unknown,Unknown,10,0-10,1.0
CO-101-001,CO-101-001-094-001,01094001,094,84.0,YEARS,81-90,5.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,168.9,>150-175,5.0,55.6,>50-75,2.0,1.62,>1.50-1.75,3.0,6010.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-22,259.0,2012-03-19,2012-04-23,2012-10-01,Died,2.0,4.0,12.254620123203285,>12-24,4.0,6.537987679671458,>6-12,3.0,5.749486652977413,Y,Y,2.0,2,2.0,Y,Y,,,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,T2,N1,0,0-10,1.0
CO-101-001,CO-101-001-094-002,01094002,094,64.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,166.4,>150-175,5.0,55.0,>50-75,2.0,1.64,>1.50-1.75,3.0,44000.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-11-10,29.0,2011-11-07,,2012-10-01,Died,2.0,3.0,0.75564681724846,<=3,1.0,0.4271047227926078,<=3,1.0,0.3613963039014374,Y,Y,2.0,2,2.0,,,Y,,,,Y,Unknown,BODY OF PANCREAS,T2,Nx,0,0-10,1.0
CO-101-001,CO-101-001-094-003,01094003,094,63.0,YEARS,61-70,3.0,<65,1.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,150.0,>125-150,4.0,56.4,>50-75,2.0,1.52,>1.50-1.75,3.0,167.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-26,143.0,2012-04-25,2012-05-27,2012-10-01,Died,2.0,2.0,1.4127310061601643,<=3,1.0,0.7227926078028748,<=3,1.0,0.7227926078028748,Y,Y,2.0,2,2.0,,Y,,Y,,,,G1 - Well differentiated,BODY OF PANCREAS,T4,N1,90,81-90,9.0
CO-101-001,CO-101-001-094-004,01094004,094,80.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,170.2,>150-175,5.0,74.4,>50-75,2.0,1.88,>1.75-2.0,4.0,17900.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,UNKNOWN ACUTE CARDIOVASCULAR EVENT,2012-02-29,22.0,2012-02-27,2012-02-29,2012-10-01,Died,2.0,2.0,0.5256673511293635,<=3,1.0,0.459958932238193,<=3,1.0,0.09856262833675565,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,N1,60,51-60,6.0
CO-101-001,CO-101-001-095-002,01095002,095,82.0,YEARS,81-90,5.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,165.1,>150-175,5.0,64.0,>50-75,2.0,1.84,>1.75-2.0,4.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-09-03,376.0,2012-08-07,2012-08-07,2012-10-01,Died,2.0,2.0,3.7125256673511293,>3-6,2.0,1.2484599589322383,<=3,1.0,2.4969199178644765,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,T2,N0,0,0-10,1.0
CO-101-001,CO-101-001-095-003,01095003,095,67.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,182.9,>175,6.0,86.6,>75-100,3.0,2.08,>2.0,5.0,10100.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-10-08,55.0,2011-10-05,2011-10-05,2012-10-01,Died,2.0,1.0,0.6242299794661191,<=3,1.0,0.5913757700205339,<=3,1.0,0.06570841889117043,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,Nx,70,61-70,7.0
CO-101-001,CO-101-001-095-005,01095005,095,84.0,YEARS,81-90,5.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,,,,63.5,>50-75,2.0,1.67,>1.50-1.75,3.0,,,,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-13,157.0,2012-07-10,2012-07-10,2012-10-01,Died,2.0,2.0,0.919917864476386,<=3,1.0,0.4271047227926078,<=3,1.0,0.5256673511293635,Y,Y,2.0,2,2.0,Y,,,Y,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Unknown,Unknown,20,11-20,2.0
CO-101-001,CO-101-001-095-006,01095006,095,70.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,185.4,>175,6.0,81.2,>75-100,3.0,2.0,>1.75-2.0,4.0,36.5,<=ULN,1.0,Y,Y,Y,N,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,,,,,,,,2012-10-30,,2012-10-01,,,4.0,0.75564681724846,<=3,1.0,0.75564681724846,<=3,1.0,0.03285420944558522,N,Y,1.0,1,1.0,,,,,,,Y,Unknown,PANCREATIC DUCT,Unknown,Unknown,40,31-40,4.0
CO-101-001,CO-101-001-095-007,01095007,095,78.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.6,>150-175,5.0,58.1,>50-75,2.0,1.8,>1.75-2.0,4.0,337.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-06,59.0,2012-05-14,,2012-10-01,Died,2.0,1.0,0.4271047227926078,<=3,1.0,0.4271047227926078,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,BODY OF PANCREAS,Unknown,Unknown,95,91-100,10.0
CO-101-001,CO-101-001-096-002,01096002,096,67.0,YEARS,61-70,3.0,>=65,2.0,M,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,170.0,>150-175,5.0,76.4,>75-100,3.0,1.88,>1.75-2.0,4.0,1620.0,>20xULN-50xULN,6.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-05-15,155.0,2012-04-27,2012-04-27,2012-10-01,Died,2.0,2.0,1.5770020533880904,<=3,1.0,1.5770020533880904,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,Y,,,,Y,G2 - Moderately differentiated,BODY OF PANCREAS,T4,N1,50,41-50,5.0
CO-101-001,CO-101-001-097-001,01097001,097,67.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,172.0,>150-175,5.0,75.3,>75-100,3.0,1.88,>1.75-2.0,4.0,17500.0,>50xULN,7.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-29,312.0,2012-07-25,2012-07-29,2012-10-01,Died,2.0,4.0,2.6940451745379876,<=3,1.0,2.431211498973306,<=3,1.0,0.29568788501026694,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,Unknown,Unknown,N/A,,
CO-101-001,CO-101-001-097-002,01097002,097,52.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.3,>150-175,5.0,48.3,<=50,1.0,1.48,>1.25-1.50,2.0,21100.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2011-12-01,,2012-10-01,Withdrew consent from monthly follow-up,4.0,2.0,1.6098562628336757,<=3,1.0,1.6427104722792607,<=3,1.0,0.0,Y,Y,2.0,2,2.0,Y,,,Y,,,,Unknown,HEAD OF PANCREAS,Unknown,Unknown,90,81-90,9.0
CO-101-001,CO-101-001-097-004,01097004,097,67.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.5,>150-175,5.0,58.4,>50-75,2.0,1.65,>1.50-1.75,3.0,1920.0,>50xULN,7.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,SUBACUTE BACTERIAL PERONTINITS SECONDARY TO ASCITES SECONDARY TO DISEASE PROGRESSION,2012-01-17,83.0,2011-12-14,,2012-10-01,Died,2.0,2.0,2.135523613963039,<=3,1.0,2.135523613963039,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,Y,Y,,,,,Unknown,TAIL OF PANCREAS,Unknown,Unknown,35,31-40,4.0
CO-101-001,CO-101-001-097-006,01097006,097,54.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,181.7,>175,6.0,89.1,>75-100,3.0,2.13,>2.0,5.0,143000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-06-07,211.0,2012-05-09,2012-06-07,2012-10-01,Died,2.0,2.0,0.9856262833675564,<=3,1.0,0.9856262833675564,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,Unknown,OTHER,Unknown,Unknown,50,41-50,5.0
CO-101-001,CO-101-001-097-008,01097008,097,68.0,YEARS,61-70,3.0,>=65,2.0,F,ASIAN,2.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,152.0,>150-175,5.0,42.4,<=50,1.0,1.34,>1.25-1.50,2.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-24,239.0,2012-08-22,2012-08-24,2012-10-01,Died,2.0,8.0,2.3983572895277208,<=3,1.0,1.8726899383983573,<=3,1.0,0.5585215605749486,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,OTHER,Tx,Nx,60,51-60,6.0
CO-101-001,CO-101-001-097-010,01097010,097,56.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.5,>150-175,5.0,56.4,>50-75,2.0,1.6,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-23,,2012-10-01,,,2.0,2.5626283367556466,<=3,1.0,0.75564681724846,<=3,1.0,1.839835728952772,Y,Y,2.0,2,2.0,Y,Y,,,,,,Unknown,HEAD OF PANCREAS,Tx,Nx,20,11-20,2.0
CO-101-001,CO-101-001-097-011,01097011,097,59.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,CAN,CANADA,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,160.5,>150-175,5.0,68.5,>50-75,2.0,1.76,>1.75-2.0,4.0,87600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-10-02,190.0,2012-09-17,2012-10-02,2012-10-01,Died,2.0,5.0,1.4127310061601643,<=3,1.0,1.4127310061601643,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,GX - Grade cannot be assessed,HEAD OF PANCREAS,Unknown,Unknown,25,21-30,3.0
CO-101-001,CO-101-001-098-002,01098002,098,75.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,175.3,>175,6.0,77.1,>75-100,3.0,1.95,>1.75-2.0,4.0,10400.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-08-06,413.0,2012-07-03,2012-07-03,2012-10-01,Died,2.0,2.0,0.6570841889117043,<=3,1.0,0.6570841889117043,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,Y,Y,,,,,,G4 - Undifferentiated,BODY OF PANCREAS,Unknown,N1,30,21-30,3.0
CO-101-001,CO-101-001-098-003,01098003,098,70.0,YEARS,61-70,3.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,177.8,>175,6.0,103.4,>100-125,4.0,2.0,>1.75-2.0,4.0,2950.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,DISEASE UNDER STUDY,2012-02-27,243.0,2012-02-23,,2012-10-01,Died,2.0,2.0,0.6899383983572895,<=3,1.0,0.29568788501026694,<=3,1.0,0.4271047227926078,Y,Y,4.0,4,4.0,Y,,Y,Y,,,Y,G2 - Moderately differentiated,HEAD OF PANCREAS,T4,Nx,95,91-100,10.0
CO-101-001,CO-101-001-098-006,01098006,098,50.0,YEARS,<=50,1.0,<65,1.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.6,>150-175,5.0,97.1,>75-100,3.0,2.13,>2.0,5.0,28000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,WITHDRAWAL BY SUBJECT,5.0,WITHDREW CONSENT,Y,CAUSE UNKNOWN,2011-11-15,111.0,2011-10-24,2011-10-24,2012-10-01,Died,2.0,10.0,0.919917864476386,<=3,1.0,0.919917864476386,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,Unknown,HEAD OF PANCREAS,Unknown,Unknown,60,51-60,6.0
CO-101-001,CO-101-001-098-012,01098012,098,54.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,180.3,>175,6.0,77.0,>75-100,3.0,1.96,>1.75-2.0,4.0,278.0,>3xULN-10xULN,4.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-19,171.0,2012-07-10,2012-07-10,2012-10-01,Died,2.0,5.0,1.051334702258727,<=3,1.0,0.5256673511293635,<=3,1.0,0.5585215605749486,Y,Y,2.0,2,2.0,Y,,,,,,Y,G3 - Poorly differentiated,HEAD OF PANCREAS,T2,N0,95,91-100,10.0
CO-101-001,CO-101-001-100-001,01100001,100,67.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,177.8,>175,6.0,78.0,>75-100,3.0,1.96,>1.75-2.0,4.0,66.7,>ULN-2xULN,2.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-03-21,231.0,2012-03-06,2012-03-06,2012-10-01,Died,2.0,2.0,0.7885010266940452,<=3,1.0,0.26283367556468173,<=3,1.0,0.5585215605749486,Y,Y,2.0,2,2.0,,Y,,Y,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-100-002,01100002,100,82.0,YEARS,81-90,5.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,152.4,>150-175,5.0,56.2,>50-75,2.0,1.52,>1.50-1.75,3.0,16500.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2011-12-29,133.0,2011-12-19,2011-12-19,2012-10-01,Died,2.0,2.0,1.051334702258727,<=3,1.0,1.051334702258727,<=3,1.0,0.03285420944558522,Y,Y,4.0,4,4.0,,,Y,Y,,,Y,G3 - Poorly differentiated,OTHER,Tx,Nx,50,41-50,5.0
CO-101-001,CO-101-001-101-002,01101002,101,73.0,YEARS,71-80,4.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,177.8,>175,6.0,73.0,>50-75,2.0,1.9,>1.75-2.0,4.0,9770.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-10,2012-10-10,2012-10-01,Alive,1.0,2.0,1.379876796714579,<=3,1.0,0.26283367556468173,<=3,1.0,1.1498973305954825,Y,Y,1.0,1,1.0,Y,,,,,,,G2 - Moderately differentiated,HEAD OF PANCREAS,Unknown,Unknown,5,0-10,1.0
CO-101-001,CO-101-001-104-001,01104001,104,70.0,YEARS,61-70,3.0,>=65,2.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,167.6,>150-175,5.0,61.7,>50-75,2.0,1.7,>1.50-1.75,3.0,15600.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Negative (Low),1.0,DEATH,2.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-20,115.0,2012-07-18,,2012-10-01,Died,2.0,2.0,2.7926078028747434,<=3,1.0,1.3141683778234086,<=3,1.0,1.51129363449692,Y,Y,3.0,3,3.0,Y,Y,,Y,,,,Unknown,BODY OF PANCREAS,Unknown,Unknown,0,0-10,1.0
CO-101-001,CO-101-001-105-001,01105001,105,65.0,YEARS,61-70,3.0,>=65,2.0,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,167.6,>150-175,5.0,56.2,>50-75,2.0,1.63,>1.50-1.75,3.0,21000.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Negative (Low),1.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-04-28,292.0,2012-04-20,2012-04-20,2012-10-01,Died,2.0,2.0,1.51129363449692,<=3,1.0,1.51129363449692,<=3,1.0,0.03285420944558522,Y,Y,2.0,2,2.0,,Y,Y,,,,,Unknown,BODY OF PANCREAS,T4,N0,0,0-10,1.0
CO-101-001,CO-101-001-105-002,01105002,105,55.0,YEARS,51-60,2.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,182.9,>175,6.0,93.4,>75-100,3.0,2.16,>2.0,5.0,63100.0,>50xULN,7.0,Y,Y,Y,Y,Y,Gemcitabine Elaidate,Gemcitabine Elaidate,1.0,Gemcitabine Elaidate,1.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,CAUSE UNKNOWN,2011-12-24,82.0,2011-11-26,,2012-10-01,Died,2.0,2.0,0.4271047227926078,<=3,1.0,0.4271047227926078,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,Y,Y,,,,,GX - Grade cannot be assessed,TAIL OF PANCREAS,Tx,N1,70,61-70,7.0
CO-101-001,CO-101-001-105-003,01105003,105,55.0,YEARS,51-60,2.0,<65,1.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,157.5,>150-175,5.0,54.4,>50-75,2.0,1.54,>1.50-1.75,3.0,48.8,>ULN-2xULN,2.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-11,2012-10-11,2012-10-01,Alive,1.0,2.0,1.051334702258727,<=3,1.0,1.051334702258727,<=3,1.0,0.03285420944558522,Y,Y,1.0,1,1.0,Y,,,,,,,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,Nx,80,71-80,8.0
CO-101-001,CO-101-001-106-001,01106001,106,79.0,YEARS,71-80,4.0,>=65,2.0,F,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,0.0,1.0,0.0,0,1.0,157.0,>150-175,5.0,61.7,>50-75,2.0,1.62,>1.50-1.75,3.0,24.4,<=ULN,1.0,Y,Y,Y,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,Positive (High),2.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,DISEASE PROGRESSION,2012-07-14,250.0,2012-07-02,2012-07-02,2012-10-01,Died,2.0,2.0,1.1498973305954825,<=3,1.0,1.5770020533880904,<=3,1.0,-0.3942505133470226,Y,Y,3.0,3,3.0,Y,Y,,,,,Y,G3 - Poorly differentiated,HEAD OF PANCREAS,T3,N1,60,51-60,6.0
CO-101-001,CO-101-001-106-002,01106002,106,78.0,YEARS,71-80,4.0,>=65,2.0,F,BLACK OR AFRICAN AMERICAN,3.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,160.8,>150-175,5.0,61.2,>50-75,2.0,1.64,>1.50-1.75,3.0,67600.0,>50xULN,7.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,ADVERSE EVENT,3.0,ADVERSE EVENT,Y,DISEASE PROGRESSION,2012-02-06,21.0,2012-01-17,,2012-10-01,Died,2.0,7.0,1.1827515400410678,<=3,1.0,1.1827515400410678,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,Y,,,Y,,,Y,Unknown,HEAD OF PANCREAS,T2,N1,N/A,,
CO-101-001,CO-101-001-106-003,01106003,106,72.0,YEARS,71-80,4.0,>=65,2.0,M,ASIAN,2.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,162.1,>150-175,5.0,65.3,>50-75,2.0,1.7,>1.50-1.75,3.0,1.4,<=ULN,1.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,,,,,2012-10-16,2012-10-16,2012-10-01,Alive,1.0,2.0,2.004106776180698,<=3,1.0,2.004106776180698,<=3,1.0,0.03285420944558522,Y,Y,3.0,3,3.0,,Y,,Y,,,Y,G2 - Moderately differentiated,HEAD OF PANCREAS,T3,N0,N/A,,
CO-101-001,CO-101-001-110-001,01110001,110,61.0,YEARS,61-70,3.0,<65,1.0,M,WHITE,5.0,USA,UNITED STATES,North America,1.0,North America,1.0,US/Western Europe/Australia,1.0,1.0,1.0,1.0,1,2.0,175.3,>175,6.0,74.4,>50-75,2.0,1.9,>1.75-2.0,4.0,22600.0,>50xULN,7.0,Y,Y,N,Y,N,Gemcitabine,Gemcitabine,2.0,Gemcitabine,2.0,N/A,3.0,PROGRESSIVE DISEASE,1.0,DISEASE PROGRESSION,Y,CAUSE UNKNOWN,2012-05-09,169.0,2012-04-06,2012-05-09,2012-10-01,Died,2.0,2.0,0.8542094455852156,<=3,1.0,0.1971252566735113,<=3,1.0,0.6899383983572895,Y,Y,4.0,4,4.0,Y,Y,,Y,,,Y,G3 - Poorly differentiated,TAIL OF PANCREAS,T3,Nx,N/A,,
